https://curecurrent.com/trials/clinical-trial-to-evaluate-the-immunogenicity-and-safety-of-an-adjuvanted-a-h1n1-v-influenza-vaccine-and-a-non-adjuvante-126008https://curecurrent.com/trials/intensification-with-enfuvirtide-in-naive-hiv-infected-patients-anrs130-126009https://curecurrent.com/trials/prevention-of-perinatal-transmission-of-hiv-1-without-nucleoside-reverse-transcriptase-inhibitors-126010https://curecurrent.com/trials/anti-retroviral-therapy-medications-for-opioid-use-disorder-opioids-and-hiv-infection-study-1-126011https://curecurrent.com/trials/national-multicenter-trial-evaluating-two-treatments-in-patients-with-primary-human-immunodeficiency-virus-hiv-1-infecti-126012https://curecurrent.com/trials/cannabis-hiv-and-mental-processing-systems-126013https://curecurrent.com/trials/prevention-of-hiv1-mother-to-child-transmission-without-nucleoside-analogue-reverse-transcriptase-inhibitors-in-the-pre-126014https://curecurrent.com/trials/trial-comparing-two-strategies-of-vaccination-against-hepatitis-b-in-hiv-infected-patients-non-responding-to-primary-imm-126015https://curecurrent.com/trials/early-and-intermittent-antiretroviral-therapy-in-naive-hiv-infected-adults-126016https://curecurrent.com/trials/the-anrs-co21-extreme-cohort-codex-126017https://curecurrent.com/trials/propranolol-for-the-treatment-of-kaposi-sarcoma-in-adults-126018https://curecurrent.com/trials/trial-comparing-three-strategies-of-vaccination-against-the-virus-of-hepatitis-b-in-hiv-infected-patients-126019https://curecurrent.com/trials/raltegravir-in-patients-with-end-stage-liver-disease-and-in-transplant-recipients-126020https://curecurrent.com/trials/entre-herman-s-promoting-health-among-latino-msm-126021https://curecurrent.com/trials/pre-exposure-prophylaxis-prep-gender-affirming-hormone-therapy-gaht-interactions-in-tgw-126022https://curecurrent.com/trials/efficacy-and-tolerance-of-the-switch-from-enfuvirtine-to-raltegravir-in-antiretroviral-therapy-regimen-in-hiv-patients-w-126023https://curecurrent.com/trials/the-implementation-of-a-trans-tailored-harm-reduction-service-for-transgender-persons-in-relation-to-chemsex-and-substan-126024https://curecurrent.com/trials/evaluation-of-maraviroc-intensification-in-hiv-infected-patients-with-insufficient-immune-restoration-126025https://curecurrent.com/trials/anrs-hc20-effectiveness-of-an-optimized-anti-hcv-pegifn-alpha2a-ribavirin-on-sustained-virological-response-in-patients-126026https://curecurrent.com/trials/pre-implementation-study-to-develop-trans-tailored-services-for-transgender-persons-in-relation-to-chemsex-126027https://curecurrent.com/trials/combined-prevention-of-sexually-transmitted-infections-stis-in-men-who-have-sex-with-men-and-using-oral-tenofovir-disopr-126028https://curecurrent.com/trials/ehealth-as-an-aid-for-facilitating-and-supporting-self-management-in-families-with-long-term-childhood-illness-126029https://curecurrent.com/trials/prep-and-moud-rapid-access-for-persons-who-inject-drugs-the-chorus-study-126030https://curecurrent.com/trials/host-led-harm-reduction-approach-among-men-who-have-sex-with-men-who-engaged-in-chemsex-in-bangkok-thailand-a-pre-implem-126031https://curecurrent.com/trials/measure-of-pharmacokinetic-parameters-and-adherence-with-mems-in-naive-hiv-infected-patients-treated-with-reyataz-once-d-126032https://curecurrent.com/trials/engaging-pharmacists-to-advance-tobacco-treatment-service-delivery-126033https://curecurrent.com/trials/evaluation-of-long-acting-injectable-lai-and-teen-clubs-in-adolescents-attune-126034https://curecurrent.com/trials/rosuvastatin-versus-pravastatin-in-hiv-patients-treated-with-boosted-protease-inhibitors-pi-anrs126-126035https://curecurrent.com/trials/evaluation-of-a-dose-reduction-of-darunavir-400-mg-d-in-virologically-suppressed-hiv-1-patients-126036https://curecurrent.com/trials/lenalidomide-in-kaposi-disease-associated-with-hiv-infection-126037https://curecurrent.com/trials/capacity-of-the-dual-combination-raltegravir-etravirine-to-maintain-virological-success-in-hiv-1-infected-patients-of-at-126038https://curecurrent.com/trials/efficacy-of-using-interleukin-2-in-antiretroviral-na-ve-hiv-patients-anrs119-126039https://curecurrent.com/trials/california-meps-hub-126040https://curecurrent.com/trials/evaluation-of-mhealth-intervention-to-promote-hiv-prevention-and-overcome-stigma-among-transgender-women-empow-her-126041https://curecurrent.com/trials/efficacy-of-alendronate-versus-placebo-in-the-treatment-of-hiv-associated-osteoporosis-anrs120-126042https://curecurrent.com/trials/behavioral-risk-identification-and-decision-guidance-for-hiv-engagement-126043https://curecurrent.com/trials/evaluation-of-raltegravir-plus-maraviroc-therapy-in-controlled-hiv-patients-presenting-with-lipohypertrophy-126044https://curecurrent.com/trials/behavioral-and-psychosocial-characteristics-of-clients-accessing-services-at-ihri-126045https://curecurrent.com/trials/implementation-and-deliver-of-lenacapavir-for-prep-in-a-community-pharmacy-setting-126046https://curecurrent.com/trials/dual-boosted-protease-inhibitor-regimens-without-any-additional-antiretroviral-therapy-in-hiv-1-infected-patients-anrs12-126047https://curecurrent.com/trials/telaprevir-in-hiv-hcv-coinfected-patients-who-had-previously-failed-a-peginterferon-ribavirin-regimen-126048https://curecurrent.com/trials/early-intensification-of-antiretroviral-therapy-including-enfuvirtide-in-hiv-1-related-progressive-multifocal-leucoencep-126049https://curecurrent.com/trials/brief-acceptance-and-commitment-therapy-for-hiv-infected-at-risk-drinkers-126050https://curecurrent.com/trials/pk-safety-study-of-90-day-use-of-vaginal-rings-containing-dapivirine-and-levonorgestrel-126051https://curecurrent.com/trials/parrying-the-pitfalls-of-prep-project-peach-126052https://curecurrent.com/trials/modeling-the-effects-of-chronic-marijuana-use-on-neuroinflammation-and-hiv-related-neuronal-injury-126053https://curecurrent.com/trials/digital-limited-interaction-efficacy-trial-of-lifeskills-mobile-to-reduce-hiv-incidence-in-ytw-126054https://curecurrent.com/trials/preliminary-assessment-of-safety-and-tolerability-of-dostarlimab-in-combination-antiretroviral-therapy-cart-refractory-h-126055https://curecurrent.com/trials/ed2prep-patient-focused-low-burden-strategies-for-prep-uptake-among-emergency-departments-126056https://curecurrent.com/trials/3bnc117-ls-and-10-1074-ls-plus-n-803-bnab-n-803-126057https://curecurrent.com/trials/tracking-and-continuity-of-care-in-advanced-hiv-disease-126058https://curecurrent.com/trials/doxi-rio-study-on-the-use-of-doxycycline-to-prevent-sexually-transmitted-infections-in-rio-de-janeiro-126059https://curecurrent.com/trials/hiv-hospital-testing-bringing-the-hidden-to-light-in-the-hospital-setting-126060https://curecurrent.com/trials/the-south-east-asian-transgender-health-cohort-126061https://curecurrent.com/trials/prevention-of-mother-to-child-transmission-pmtct-among-women-experiencing-depression-in-malawi-126062https://curecurrent.com/trials/opioid-hiv-and-immune-system-126063https://curecurrent.com/trials/switch-to-doravirine-islatravir-dor-isl-in-human-immunodeficiency-virus-1-hiv-1-participants-treated-with-bictegravir-em-126064https://curecurrent.com/trials/understanding-practices-of-lactation-and-infant-feeding-together-with-women-with-hiv-in-the-united-states-126065https://curecurrent.com/trials/pharmacy-based-prep-delivery-in-kenya-126066https://curecurrent.com/trials/a-trial-of-2-options-for-second-line-combination-antiretroviral-therapy-following-virological-failure-of-a-standard-non-126067https://curecurrent.com/trials/development-of-an-intervention-to-reduce-heavy-drinking-and-improve-hiv-care-engagement-among-fisherfolk-in-uganda-126068https://curecurrent.com/trials/prevent-tb-choice-architecture-for-tpt-delivery-126069https://curecurrent.com/trials/cabotegravir-lenacapavir-dual-long-acting-therapy-cohort-imea-074-126070https://curecurrent.com/trials/short-term-steroid-therapy-in-patients-with-p-jirovecii-pneumonia-due-to-hiv-aids-126071https://curecurrent.com/trials/extended-follow-up-of-the-iss-t-003-trial-volunteers-iss-t-003-ef-up2020-126072https://curecurrent.com/trials/cardiovascular-responses-to-exercise-in-people-living-with-hiv-aids-effects-of-exercise-training-126073https://curecurrent.com/trials/imprep-len-brasil-twice-yearly-lenacapavir-for-hiv-prevention-126074https://curecurrent.com/trials/adolescent-wellness-visits-in-tanzania-126075https://curecurrent.com/trials/evaluating-the-healthy-families-prep-program-for-women-at-risk-for-hiv-126076https://curecurrent.com/trials/the-decide-tb-trial-validation-of-treatment-decision-algorithms-for-childhood-tuberculosis-126077https://curecurrent.com/trials/off-label-medications-for-alcohol-use-disorder-among-patients-with-hiv-pilot-study-3-semaglutide-126078https://curecurrent.com/trials/feasibility-study-of-ocular-surface-squamous-neoplasia-surgical-excision-in-people-living-with-hiv-in-sub-saharan-africa-126079https://curecurrent.com/trials/baricitinib-for-reduction-of-hiv-cns-126080https://curecurrent.com/trials/recurrent-visceral-leishmaniasis-in-hiv-co-infection-126081https://curecurrent.com/trials/letsync-pilot-test-of-mobile-health-mhealth-intervention-126082https://curecurrent.com/trials/a-multi-level-trauma-informed-approach-to-increase-hiv-pre-exposure-prophylaxis-initiation-among-black-women-126083https://curecurrent.com/trials/transitional-housing-and-hiv-health-126084https://curecurrent.com/trials/hiv-self-testing-for-partners-of-hiv-uninfected-postpartum-women-126085https://curecurrent.com/trials/study-of-a-human-bispecific-antibody-vrc-hivmab0121-00-ab-cap256j3ls-administered-intravenously-or-subcutaneously-to-hea-126086https://curecurrent.com/trials/exploration-of-the-variability-of-exposure-to-antiretroviral-treatment-in-hair-with-a-view-to-validating-its-value-as-a-126087https://curecurrent.com/trials/a-pilot-project-for-plwh-aged-65-75-preventing-the-development-of-frailty-126088https://curecurrent.com/trials/attitudes-of-dental-students-towards-hiv-patients-a-multi-center-survey-among-italian-universities-126089https://curecurrent.com/trials/peer-led-implementation-of-tb-hiv-education-and-adherence-counseling-in-uganda-126090https://curecurrent.com/trials/facilitating-routine-hiv-testing-among-msm-by-a-subscription-based-self-test-distribution-model-126091https://curecurrent.com/trials/testing-a-novel-data-to-suppression-d2s-intervention-strategy-in-the-ryan-white-hiv-aids-program-126092https://curecurrent.com/trials/a-randomized-clinical-trial-to-evaluate-solutions-for-the-management-of-virologic-failure-on-tld-in-sub-saharan-africa-126093https://curecurrent.com/trials/digital-community-to-improve-health-in-rural-areas-126094https://curecurrent.com/trials/application-of-augmented-reality-ar-in-hiv-self-test-in-men-who-have-sex-with-men-community-126095https://curecurrent.com/trials/long-acting-cabotegravir-injectable-pre-exposure-prophylaxis-for-people-who-inject-drugs-126096https://curecurrent.com/trials/injectable-cabotegravir-compared-to-tdf-ftc-for-prep-in-hiv-uninfected-men-and-transgender-women-who-have-sex-with-men-126097https://curecurrent.com/trials/improving-quality-of-life-for-adults-living-with-hiv-and-chronic-pain-126098https://curecurrent.com/trials/safety-and-immune-responses-after-vaccination-with-two-investigational-rna-based-vaccines-against-tuberculosis-in-bcg-va-126099https://curecurrent.com/trials/mycoplasma-genitalium-infection-and-associated-antimicrobial-resistance-among-hiv-infected-male-in-hong-kong-126100https://curecurrent.com/trials/la-prep-impact-and-cost-effectiveness-teams-126101https://curecurrent.com/trials/kp-led-same-day-hcv-test-and-treat-study-126102https://curecurrent.com/trials/evaluation-of-the-effectiveness-of-the-hpv-education-program-applied-to-women-126103https://curecurrent.com/trials/the-t-cell-activator-of-cell-killing-tack-it-on-study-126104https://curecurrent.com/trials/using-implementation-science-to-increase-pre-exposure-prophylaxis-uptake-among-african-american-women-126105https://curecurrent.com/trials/mobile-hiv-prevention-app-for-black-women-126106https://curecurrent.com/trials/a-chatbot-to-reduce-chemsex-and-hiv-related-risk-behaviors-among-men-who-have-sex-with-men-126107https://curecurrent.com/trials/getting-to-zero-among-hhi-msm-in-the-american-south-126108https://curecurrent.com/trials/reactive-driven-support-for-treatment-adherence-resilience-and-thriving-restart-clinical-trial-126109https://curecurrent.com/trials/analytical-treatment-interruption-ati-to-assess-the-immune-system-s-ability-to-control-hiv-in-participants-who-became-hi-126110https://curecurrent.com/trials/antiviral-clinical-trial-for-long-covid-19-126111https://curecurrent.com/trials/phase-ii-trial-of-tesamorelin-for-cognition-in-aging-hiv-infected-persons-126112https://curecurrent.com/trials/aware-hiv-europe-supporting-healthcare-professionals-to-find-undiagnosed-hiv-in-european-hospitals-an-effectiveness-impl-126113https://curecurrent.com/trials/evaluation-of-a-rapid-point-of-care-serological-triage-test-for-active-tb-126114https://curecurrent.com/trials/ideas-for-hope-to-reduce-suicide-risk-and-improve-hiv-care-engagement-in-tanzania-126115https://curecurrent.com/trials/evaluating-the-safety-and-immunogenicity-of-mtbvac-126116https://curecurrent.com/trials/improving-access-to-hiv-testing-for-children-in-uganda-126117https://curecurrent.com/trials/suubi4stigma-addressing-hiv-associated-stigma-among-adolescents-126118https://curecurrent.com/trials/the-outreach-and-prevention-at-alcohol-venues-in-east-africa-study-opal-east-africa-aim-1-126119https://curecurrent.com/trials/enhancing-quality-interventions-promoting-healthy-sexuality-126120https://curecurrent.com/trials/icvax-as-a-hiv-therapeutic-dna-vaccine-126121https://curecurrent.com/trials/mental-health-and-medication-adherence-among-msm-in-south-africa-126122https://curecurrent.com/trials/achieving-equity-in-patient-outcome-reporting-for-timely-assessments-of-life-with-hiv-and-substance-use-126123https://curecurrent.com/trials/antiviral-long-acting-drugs-landing-in-people-living-with-hiv-126124https://curecurrent.com/trials/effect-on-body-weight-reduction-of-a-behavioral-intervention-on-lifestyle-using-a-digital-nutritional-program-in-people-126125https://curecurrent.com/trials/support-for-adolescents-living-with-hiv-in-south-africa-126126https://curecurrent.com/trials/a-study-to-evaluate-vh4524184-tablet-absorption-effects-of-food-and-interactions-with-other-drugs-in-healthy-adults-126127https://curecurrent.com/trials/pathways-to-cardiovascular-disease-prevention-dcri-central-and-statistical-coordinating-center-126128https://curecurrent.com/trials/welcome-to-prep-school-utilizing-peer-educators-to-improve-uptake-of-preexposure-prophylaxis-for-hiv-at-an-hbcu-126129https://curecurrent.com/trials/implementation-outcomes-and-cost-effectiveness-of-developmental-monitoring-for-children-exposed-to-hiv-126130https://curecurrent.com/trials/evaluating-a-new-stool-based-qpcr-for-diagnosis-of-tuberculosis-in-children-and-people-living-with-hiv-126131https://curecurrent.com/trials/the-efficacy-and-safety-study-of-car-t-cells-for-functional-cure-in-hiv-1-aids-patients-126132https://curecurrent.com/trials/pharmacokinetics-safety-and-acceptability-of-drv-r-for-children-living-with-hiv-126133https://curecurrent.com/trials/peer-led-community-based-prep-delivery-among-youth-in-brazil-126134https://curecurrent.com/trials/project-engage-a-wrist-biosensor-based-mhealth-suite-to-support-alcohol-intervention-in-young-people-living-with-hiv-126135https://curecurrent.com/trials/safety-and-pharmacokinetics-evaluation-of-fostemsavir-obt-in-hiv-1-infected-children-and-adolescents-who-are-failing-the-126136https://curecurrent.com/trials/comprehensive-geriatric-assessment-in-adults-aged-40-years-and-older-living-with-hiv-126137https://curecurrent.com/trials/education-and-employment-support-for-hiv-prevention-in-young-adults-enspire-126138https://curecurrent.com/trials/dtg-3tc-fixed-dose-formulations-for-the-maintenance-of-virological-suppression-in-children-with-hiv-infection-aged-2-to-126139https://curecurrent.com/trials/diagnosis-of-hiv-and-early-antiretroviral-therapy-initiation-among-hiv-1-infected-infants-126140https://curecurrent.com/trials/universal-1-pharmacokinetic-study-of-a-novel-dtg-ftc-taf-dose-ratio-for-children-126141https://curecurrent.com/trials/study-of-pro-140-sc-as-single-agent-maintenance-therapy-in-virally-suppressed-subjects-with-ccr5-tropic-hiv-1-infection-126142https://curecurrent.com/trials/pathtoscale-the-persist-trial-126143https://curecurrent.com/trials/developing-mhealth-to-promote-prep-use-among-thai-young-men-who-have-sex-with-men-126144https://curecurrent.com/trials/mortality-reductions-based-on-aud-heavy-alcohol-use-hiv-risk-and-cardiovascular-risk-126145https://curecurrent.com/trials/hiv-outpatient-monitoring-evaluation-through-self-collection-of-dried-blood-spots-126146https://curecurrent.com/trials/to-investigate-safety-reactogenicity-and-immunogenicity-of-vir-1388-compared-with-placebo-in-participants-without-hiv-126147https://curecurrent.com/trials/safety-and-immunogenicity-of-stabilized-ch505-tf-chtrimer-vaccination-in-adults-living-with-hiv-1-on-suppressive-antiret-126148https://curecurrent.com/trials/building-opportunities-for-nurturing-care-to-enhance-child-development-in-eastern-and-southern-africa-126149https://curecurrent.com/trials/integrated-health-services-ihs-a-structural-intervention-to-improve-hiv-sti-screening-and-prep-navigation-in-primary-car-126150https://curecurrent.com/trials/recombinant-human-interleukin-7-jl18008-for-the-treatment-of-hiv-infected-immunological-non-responders-126151https://curecurrent.com/trials/concordance-and-acceptability-of-self-screening-compared-to-screening-carried-out-by-a-health-professional-for-hpv-a-ris-126152https://curecurrent.com/trials/trial-of-ixazomib-for-kaposi-sarcoma-126153https://curecurrent.com/trials/choice-based-support-for-adults-starting-or-restarting-antiretroviral-therapy-in-cape-town-south-africa-126154https://curecurrent.com/trials/mypeeps-lite-trial-126155https://curecurrent.com/trials/in-vivo-study-of-thc-induced-immune-genome-changes-at-single-cell-solution-in-hiv-infected-humans-126156https://curecurrent.com/trials/teamwork-makes-the-dream-work-126157https://curecurrent.com/trials/comparative-effectiveness-of-individual-versus-group-level-interventions-to-increase-prep-uptake-and-reduce-hiv-sti-inci-126158https://curecurrent.com/trials/couple-based-intervention-on-quality-of-life-in-hiv-male-serodiscordant-couples-126159https://curecurrent.com/trials/improving-the-treatment-of-depression-among-youth-with-hiv-126160https://curecurrent.com/trials/boosting-the-hrqol-among-hiv-mothers-and-children-126161https://curecurrent.com/trials/reducing-intersectional-stigma-among-high-risk-women-in-brazil-to-promote-uptake-of-hiv-testing-and-prep-126162https://curecurrent.com/trials/implementation-of-screen-treat-and-triage-for-women-living-with-hiv-in-la-romana-istar-126163https://curecurrent.com/trials/treatment-responses-of-early-syphilis-to-ceftriaxone-plus-doxycycline-126164https://curecurrent.com/trials/mapping-the-human-hiv-chronobiome-126165https://curecurrent.com/trials/multidisciplinary-low-barrier-and-mobile-hiv-care-to-improve-retention-and-viral-suppression-stakeholder-engaged-design-126166https://curecurrent.com/trials/study-to-evaluate-h56-ic31-in-preventing-rate-of-tb-recurrence-126167https://curecurrent.com/trials/changes-in-bile-acids-and-microbiota-in-patients-with-hepatitis-d-treated-with-bulvertide-126168https://curecurrent.com/trials/efficacy-of-emdr-therapy-as-compared-to-treatment-as-usual-in-reducing-clinical-symptoms-in-people-with-hiv-126169https://curecurrent.com/trials/monoclonal-antibody-based-multipurpose-microbicides-126170https://curecurrent.com/trials/jomcare-study-a-harm-reduction-study-126171https://curecurrent.com/trials/improving-hiv-care-continuum-outcomes-among-formerly-incarcerated-individuals-through-critical-time-legal-interventions-126172https://curecurrent.com/trials/digital-peer-support-based-anti-hiv-stigma-intervention-among-adolescents-living-with-hiv-in-ethiopia-126173https://curecurrent.com/trials/early-infant-hiv-treatment-in-botswana-126174https://curecurrent.com/trials/cmv-specific-hiv-car-t-cells-as-immunotherapy-for-hiv-aids-126175https://curecurrent.com/trials/protect-al-prep-optimization-through-enhanced-continuum-tracking-126176https://curecurrent.com/trials/upper-gastrointestinal-endoscopy-in-hiv-infected-individuals-126177https://curecurrent.com/trials/implementation-of-long-acting-cabotegravir-rilpivirine-administration-out-of-hiv-units-126178https://curecurrent.com/trials/quality-of-care-in-french-hiv-infected-patients-126179https://curecurrent.com/trials/assessment-of-safety-and-immunogenicity-of-r21-matrix-m-in-african-children-living-with-hiv-126180https://curecurrent.com/trials/low-dose-trimethoprim-sulfamethoxazole-for-the-treatment-of-pneumocystis-jirovecii-pneumonia-126181https://curecurrent.com/trials/evaluation-of-a-reproductive-health-education-program-in-women-living-with-hiv-126182https://curecurrent.com/trials/combination-primary-care-and-prevention-services-for-women-who-inject-drugs-and-exchange-sex-in-seattle-washington-126183https://curecurrent.com/trials/mobile-health-supported-self-care-among-tertiary-education-students-in-zimbabwe-126184https://curecurrent.com/trials/phase-2b-open-label-multisite-randomized-crossover-study-of-dpp-versus-2pr-126185https://curecurrent.com/trials/doravirine-dose-optimisation-in-pregnancy-126186https://curecurrent.com/trials/methamphetamine-prep-and-intersectional-stigma-study-126187https://curecurrent.com/trials/effectiveness-of-transdiagnostic-cognitive-behavioral-therapy-for-improving-hiv-treatment-outcomes-in-south-africa-126188https://curecurrent.com/trials/simplifying-treatment-and-monitoring-for-hiv-stream-hiv-126189https://curecurrent.com/trials/the-role-of-ectopic-fat-and-heart-attack-risk-in-hiv-126190https://curecurrent.com/trials/techmpower-advancing-hiv-sud-care-and-service-delivery-for-people-in-re-entry-126191https://curecurrent.com/trials/safety-and-efficacy-of-a-switch-to-doravirine-islatravir-in-participants-with-hiv-1-mk-8591a-017-126192https://curecurrent.com/trials/alcohol-research-in-hiv-relapse-prevention-126193https://curecurrent.com/trials/voluntary-hiv-screening-in-the-general-population-in-france-126194https://curecurrent.com/trials/augmented-renal-clearance-in-neurocritical-care-126195https://curecurrent.com/trials/hiv-equity-and-addiction-training-heat-program-126196https://curecurrent.com/trials/prevalence-of-hiv-and-sexually-transmitted-infections-in-migrant-communities-in-slovakia-126197https://curecurrent.com/trials/hiv-service-delivery-and-telemedicine-through-effective-pros-126198https://curecurrent.com/trials/combined-injectable-treatment-for-hiv-and-oud-126199https://curecurrent.com/trials/comprehensive-hiv-and-harm-prevention-via-telehealth-126200https://curecurrent.com/trials/screening-for-hepatitis-b-hepatitis-c-and-aids-viruses-using-dried-blood-spot-126201https://curecurrent.com/trials/optimizing-prep-regimens-for-pregnant-women-in-sub-saharan-africa-o-prep-study-stage-1-126202https://curecurrent.com/trials/pregnancy-and-viral-infections-impact-on-pregnant-women-and-their-children-french-prospective-cohort-126203https://curecurrent.com/trials/spironolactone-and-xpb-1-integrity-in-the-tfiih-complex-126204https://curecurrent.com/trials/parent-focused-intervention-to-reduce-hiv-risk-in-gay-and-bisexual-adolescents-126205https://curecurrent.com/trials/use-of-unmanned-air-vehicles-medical-drones-to-overcome-geographical-barriers-to-delivery-of-anti-retroviral-therapy-and-126206https://curecurrent.com/trials/an-integrated-intervention-using-a-pill-ingestible-sensor-system-126207https://curecurrent.com/trials/a-social-network-approach-to-improve-hiv-prevention-and-substance-use-treatment-for-people-who-use-drugs-126208https://curecurrent.com/trials/developing-a-resiliency-intervention-to-support-healthcare-workers-engaged-in-the-provision-of-hiv-care-126209https://curecurrent.com/trials/evaluation-of-single-dosing-with-two-f-taf-tablets-among-healthy-volunteers-126210https://curecurrent.com/trials/evaluating-safety-and-immune-response-of-janssen-moderna-pfizer-bnt-and-novavax-covid-19-vaccines-for-same-and-mixed-boo-126211https://curecurrent.com/trials/a-trial-of-a-gorilla-adenovirus-vectored-networked-epitopes-vaccine-administered-to-healthy-adults-living-without-and-wi-126212https://curecurrent.com/trials/implementation-a-data-to-care-strategy-to-improve-hiv-continuum-outcomes-for-out-of-care-people-living-with-hiv-plwh-in-126213https://curecurrent.com/trials/yield-of-diagnostic-tests-and-effects-of-crofelemer-for-chronic-idiopathic-diarrhea-in-non-hiv-patients-126214https://curecurrent.com/trials/digital-intervention-to-address-stigma-among-pregnant-adolescents-living-with-hiv-126215https://curecurrent.com/trials/iprep-men-s-study-expanding-the-reach-of-prevention-for-men-in-kisumu-kenya-126216https://curecurrent.com/trials/prepwise-pilot-among-black-women-in-eastern-virginia-126217https://curecurrent.com/trials/ask-prep-assistance-services-knowledge-prep-126218https://curecurrent.com/trials/evaluating-quality-of-life-in-patients-with-aids-associated-kaposi-sarcoma-treated-with-bleomycin-and-vincristine-126219https://curecurrent.com/trials/access-accelerating-cervical-cancer-elimination-through-the-integration-of-screen-and-treat-services-126220https://curecurrent.com/trials/developing-rectal-uspe-measures-for-suppositories-project-drum-s-126221https://curecurrent.com/trials/effectiveness-of-an-integrated-treatment-to-address-smoking-cessation-and-anxiety-depression-in-people-living-with-hiv-126222https://curecurrent.com/trials/building-on-needle-exchange-to-optimize-prevention-treatment-126223https://curecurrent.com/trials/safety-tolerability-and-immunogenicity-of-alfq-in-a-hiv-vaccine-containing-a244-and-b-65321-in-healthy-adults-126224https://curecurrent.com/trials/addiction-hiv-and-tuberculosis-in-malaysian-criminal-justice-settings-126225https://curecurrent.com/trials/pilot-testing-a-behavioral-intervention-to-incorporate-advances-in-hiv-prevention-for-black-young-msm-in-alabama-126226https://curecurrent.com/trials/a-study-to-investigate-the-pharmacokinetics-safety-and-tolerability-of-two-different-formulations-of-long-acting-caboteg-126227https://curecurrent.com/trials/treatment-research-investigating-depression-effects-on-neuroimmune-targets-trident-126228https://curecurrent.com/trials/integrating-vaccination-into-hospital-care-pathways-for-vulnerable-patients-126229https://curecurrent.com/trials/dolutegravir-study-in-hiv-1-participants-completing-impaact-studies-p1093-and-p2019-126230https://curecurrent.com/trials/mobile-phone-messaging-to-improve-reproductive-health-for-women-living-with-hiv-in-kenya-mobile-wach-empower-126231https://curecurrent.com/trials/a-study-of-reduced-dosing-of-the-nonavalent-hpv-vaccine-in-women-living-with-hiv-126232https://curecurrent.com/trials/safety-and-immunogenicity-of-v116-in-adults-living-with-human-immunodeficiency-virus-hiv-v116-007-stride-7-126233https://curecurrent.com/trials/kaposi-sarcoma-chemotherapy-and-research-ks-care-126234https://curecurrent.com/trials/align-a-non-randomised-study-delivering-injectable-lenacapavir-for-hiv-prevention-within-a-pre-exposure-prophylaxis-prep-126235https://curecurrent.com/trials/developing-rectal-uspe-measures-126236https://curecurrent.com/trials/magia-h3s-point-of-care-test-performance-for-hiv-hbv-hcv-and-syphilis-screening-in-pregnant-women-in-dr-congo-126237https://curecurrent.com/trials/oral-isl-qm-as-prep-in-cisgender-women-at-high-risk-for-hiv-1-infection-mk-8591-022-126238https://curecurrent.com/trials/acceptance-and-commitment-therapy-for-hiv-hazardous-drinkers-126239https://curecurrent.com/trials/optimizing-malaria-and-hiv-treatment-in-a-shifting-landscape-in-africa-126240https://curecurrent.com/trials/strategies-to-achieve-viral-suppression-for-youth-with-hiv-126241https://curecurrent.com/trials/study-evaluating-the-safety-and-efficacy-of-islatravir-in-combination-with-lenacapavir-in-virologically-suppressed-peopl-126242https://curecurrent.com/trials/combining-latency-reversing-agents-to-address-the-hiv-reservoir-126243https://curecurrent.com/trials/advancing-access-to-hiv-hcv-testing-for-people-who-inject-drugs-pwid-126244https://curecurrent.com/trials/in-this-together-r01-126245https://curecurrent.com/trials/pharmacist-led-intervention-for-injectable-hiv-treatment-for-women-with-health-related-social-needs-126246https://curecurrent.com/trials/clinical-performance-evaluation-of-magia-ivd-md-multiplex-testing-hiv-hbv-hcv-syphilis-126247https://curecurrent.com/trials/the-dc-cohort-longitudinal-hiv-status-neutral-study-126248https://curecurrent.com/trials/supporting-oral-pre-exposure-prophylaxis-decision-making-among-pregnant-women-in-lilongwe-malawi-126249https://curecurrent.com/trials/observational-study-of-people-living-with-hiv-treated-with-cd19-directed-car-t-cell-126250https://curecurrent.com/trials/universal-test-and-connect-for-hiv-service-delivery-in-south-africa-126251https://curecurrent.com/trials/long-acting-injectable-hiv-prep-pros-126252https://curecurrent.com/trials/doravirine-versus-integrase-inhibitors-on-backbone-of-emtricitabine-and-tenofovir-alafenamide-in-hiv-126253https://curecurrent.com/trials/valganciclovir-for-cmv-viraemia-in-advanced-hiv-disease-126254https://curecurrent.com/trials/efficacy-of-mhealth-e-navigator-stepped-care-intervention-for-art-adherence-among-latino-men-with-hiv-126255https://curecurrent.com/trials/prepare-scale-scaling-up-integrated-prep-delivery-in-kenyan-maternal-and-child-health-clinics-126256https://curecurrent.com/trials/prevalence-of-epstein-barr-virus-infection-126257https://curecurrent.com/trials/adaptive-text-messaging-and-non-monetary-incentives-to-sustain-art-adherence-among-adolescents-living-with-hiv-in-ethiop-126258https://curecurrent.com/trials/hiv-self-testing-with-online-supervision-for-vietnamese-msm-126259https://curecurrent.com/trials/leveraging-mhealth-to-enable-and-adapt-chw-strategies-to-improve-tb-hiv-patient-outcomes-in-sa-126260https://curecurrent.com/trials/evaluating-safety-and-immune-response-to-the-hiv-1-ch505-transmitted-founder-gp120-adjuvanted-with-gla-se-in-healthy-hiv-126261https://curecurrent.com/trials/hpv-vaccine-therapy-in-reducing-high-grade-cervical-lesions-in-patients-with-hiv-and-hpv-126262https://curecurrent.com/trials/hiv-sti-hcv-testing-and-overdose-prevention-among-survivors-of-sex-trafficking-126263https://curecurrent.com/trials/more-options-for-children-and-adolescents-mocha-oral-and-long-acting-injectable-cabotegravir-and-rilpivirine-in-hiv-infe-126264https://curecurrent.com/trials/sexual-health-access-at-retail-pharmacies-advancing-pharmacy-based-delivery-of-primary-sti-and-hiv-prevention-for-cisgen-126265https://curecurrent.com/trials/the-cleveland-cardiometabolic-cohort-126266https://curecurrent.com/trials/evaluating-an-algorithm-based-implementation-strategy-to-improve-hiv-care-outcomes-126267https://curecurrent.com/trials/dsd-models-at-malawi-sentinel-sites-sentinel-2-malawi-126268https://curecurrent.com/trials/multiplo-tp-hiv-self-test-126269https://curecurrent.com/trials/ibis-megastudy-of-interventions-to-encourage-hiv-retesting-126270https://curecurrent.com/trials/co-developing-an-hiv-prevention-program-for-women-in-ghana-126271https://curecurrent.com/trials/ibis-megastudy-pilot-126272https://curecurrent.com/trials/clinic-based-hiv-identification-and-prevention-project-using-electronic-resources-126273https://curecurrent.com/trials/doxycycline-for-emphysema-in-people-living-with-hiv-the-depth-trial-126274https://curecurrent.com/trials/academic-detailing-to-optimize-prep-implementation-in-pediatric-primary-care-settings-adopt-prep-126275https://curecurrent.com/trials/inflammation-in-hiv-aids-inflammaids-126276https://curecurrent.com/trials/an-avatar-based-mobile-phone-intervention-to-promote-health-in-african-american-msm-126277https://curecurrent.com/trials/dose-ranging-switch-study-of-islatravir-mk-8591-and-ulonivirine-mk-8507-once-weekly-in-virologically-suppressed-adults-w-126278https://curecurrent.com/trials/pragmatic-use-of-next-generation-sequencing-for-management-of-drug-resistant-tuberculosis-126279https://curecurrent.com/trials/scope-analytic-treatment-interruption-protocol-126280https://curecurrent.com/trials/screen-treat-and-retain-meth-using-people-with-opioid-use-disorders-at-methadone-clinics-126281https://curecurrent.com/trials/prevalence-and-predictors-of-hepatic-steatosis-in-persons-living-with-hiv-126282https://curecurrent.com/trials/paclitaxel-and-pegylated-liposomal-doxorubicin-for-treatment-of-hiv-related-kaposi-sarcoma-126283https://curecurrent.com/trials/implementation-of-prep-care-among-women-in-family-planning-clinics-126284https://curecurrent.com/trials/evaluation-of-trimer-4571-therapeutic-vaccination-in-adults-living-with-hiv-on-suppressive-antiretroviral-therapy-126285https://curecurrent.com/trials/prospective-clinical-trial-of-hiv-living-donor-kidney-donation-for-hiv-recipients-126286https://curecurrent.com/trials/interleukin-15-to-promote-post-art-control-of-hiv-126287https://curecurrent.com/trials/we-intervention-among-chinese-hiv-serodiscordant-male-couples-126288https://curecurrent.com/trials/positioning-second-line-therapies-for-pneumocystis-jirovecii-pneumonia-pcp-alternatives-126289https://curecurrent.com/trials/chalo-2-0-a-mobile-technology-based-intervention-to-accelerate-hiv-testing-and-linkage-to-preventive-treatment-126290https://curecurrent.com/trials/promoting-employment-in-persons-living-with-hiv-aids-126291https://curecurrent.com/trials/study-of-vrc07-523ls-cap256v2ls-and-vesatolimod-in-early-antiretroviral-treated-hiv-1-clade-c-infected-women-126292https://curecurrent.com/trials/project-speed-streamlined-protocol-for-early-engagement-and-delivery-of-hiv-prevention-with-long-acting-injectable-cabot-126293https://curecurrent.com/trials/dat-aids-prevention-126294https://curecurrent.com/trials/nonalcoholic-fatty-liver-disease-in-hiv-database-126295https://curecurrent.com/trials/hiv-suicide-prevention-with-ai-dbt-126296https://curecurrent.com/trials/randomized-controlled-trial-of-game-changers-126297https://curecurrent.com/trials/the-unlocking-prep-study-integration-of-peer-health-navigation-into-comprehensive-re-entry-services-126298https://curecurrent.com/trials/ayahiv-role-based-responsibilities-for-oncology-focused-workforce-arrow-126299https://curecurrent.com/trials/a-clinical-trial-to-evaluate-the-safety-and-immunogenicity-of-ch505m5-n197d-mrna-gp160-followed-by-ch505-tf-mrna-gp160-i-126300https://curecurrent.com/trials/the-study-of-immunization-in-people-living-with-hiv-undergoing-an-ati-for-elicitation-of-vrc01-lineage-antibodies-126301https://curecurrent.com/trials/social-network-intervention-to-engage-community-plh-to-engage-in-hiv-medical-care-126302https://curecurrent.com/trials/planning-a-multi-level-intervention-to-reduce-substance-use-stigma-in-hiv-prevention-and-care-126303https://curecurrent.com/trials/urban-gardening-and-peer-nutritional-counseling-for-people-with-hiv-and-food-insecurity-126304https://curecurrent.com/trials/hiv-treatment-retention-interventions-for-women-living-with-hiv-siyaphambili-study-126305https://curecurrent.com/trials/suubi-adherence4youth-126306https://curecurrent.com/trials/evaluating-a-youth-focused-economic-empowerment-approach-to-hiv-treatment-adherence-126307https://curecurrent.com/trials/long-term-clinical-immunologic-and-virologic-profiles-of-children-who-received-early-treatment-for-hiv-126308https://curecurrent.com/trials/efficacy-of-human-papillomavirus-hpv-vaccination-to-prevent-infection-among-women-living-with-hiv-126309https://curecurrent.com/trials/data-science-and-qualitative-research-for-decision-support-in-the-hiv-care-cascade-126310https://curecurrent.com/trials/african-canadian-study-of-hiv-infected-adults-and-a-vaccine-for-ebola-achiv-ebola-126311https://curecurrent.com/trials/peer-supported-collaborative-care-mental-health-and-substance-use-disorder-care-126312https://curecurrent.com/trials/botswana-smoking-and-abstinence-reinforcement-trial-126313https://curecurrent.com/trials/reducing-mobility-associated-interruption-in-hiv-treatment-in-malawi-126314https://curecurrent.com/trials/study-to-evaluate-the-pharmacokinetics-safety-and-antiviral-activity-of-the-elvitegravir-cobicistat-emtricitabine-tenofo-126315https://curecurrent.com/trials/how-long-should-we-give-steroids-for-patients-with-severe-pcp-126316https://curecurrent.com/trials/using-mobile-technology-to-prevent-hiv-and-related-youth-health-problems-126317https://curecurrent.com/trials/quality-of-life-related-to-the-care-of-women-living-with-hiv-during-the-perinatal-period-126318https://curecurrent.com/trials/preferences-for-services-in-a-patient-s-first-six-months-on-antiretroviral-therapy-for-hiv-in-south-africa-126319https://curecurrent.com/trials/dsd-models-at-south-africa-sentinel-sites-126320https://curecurrent.com/trials/preferences-for-services-in-a-patient-s-first-six-months-on-antiretroviral-therapy-for-hiv-in-zambia-126321https://curecurrent.com/trials/dsd-models-at-zambia-sentinel-sites-sentinel-2-126322https://curecurrent.com/trials/safety-and-pharmacokinetic-study-of-oral-mk-8527-qm-in-participants-at-low-risk-for-hiv-1-infection-mk-8527-007-126323https://curecurrent.com/trials/a-phase-a-clinical-study-of-cl-197-capsules-126324https://curecurrent.com/trials/testing-new-strategies-for-patients-hospitalised-with-hiv-associated-disseminated-tuberculosis-126325https://curecurrent.com/trials/optimizing-tobacco-treatment-delivery-for-people-living-with-hiv-126326https://curecurrent.com/trials/socio-structural-intervention-to-improve-pre-exposure-prophylaxis-services-for-cisgender-women-126327https://curecurrent.com/trials/missed-opportunities-for-hiv-screening-in-general-practice-126328https://curecurrent.com/trials/a-smart-approach-to-treating-tobacco-use-disorder-in-persons-living-with-hiv-126329https://curecurrent.com/trials/immunogenicity-and-safety-of-inactivated-hepatitis-a-vaccine-in-hiv-infected-people-126330https://curecurrent.com/trials/questioning-the-epidemiology-of-asymptomatic-tb-126331https://curecurrent.com/trials/study-of-autophagy-and-the-effects-of-galig-gene-products-in-hiv-1-infected-patients-who-are-under-antiretroviral-therap-126332https://curecurrent.com/trials/impact-of-pain-from-injectables-antiretroviral-treatments-in-hiv-1-patients-based-on-the-injection-site-ventrogluteal-or-126333https://curecurrent.com/trials/buddhist-understanding-and-reduction-of-myanmar-experiences-of-hiv-stigma-and-exclusion-126334https://curecurrent.com/trials/enhancing-uptake-of-needle-and-syringe-programs-in-canadian-federal-prisons-126335https://curecurrent.com/trials/a-study-to-investigate-safety-tolerability-and-pharmacokinetics-pk-of-vh4524184-and-the-potential-for-changes-in-cytochr-126336https://curecurrent.com/trials/optimizing-cab-la-as-prep-for-women-who-inject-drugs-126337https://curecurrent.com/trials/prevention-of-hiv-and-stds-in-drug-using-women-126338https://curecurrent.com/trials/improving-hiv-care-engagement-among-ugandan-adolescent-girls-and-young-women-the-kisoboka-mukwano-intervention-126339https://curecurrent.com/trials/trial-to-evaluate-the-interest-of-a-reductive-anti-retroviral-strategy-using-dual-therapy-inspite-of-triple-therapy-126340https://curecurrent.com/trials/addressing-the-continuum-of-care-among-high-risk-thai-men-126341https://curecurrent.com/trials/analysis-of-cellular-kinases-and-aging-in-pbmcs-and-colorectal-tissue-126342https://curecurrent.com/trials/strengthening-families-living-with-hiv-in-kenya-126343https://curecurrent.com/trials/phase-1-clinical-trial-to-evaluate-the-safety-and-immunogenicity-of-hiv-1-chimp-adenovirus-vaccines-expressing-clade-c-g-126344https://curecurrent.com/trials/study-of-a-cohort-of-non-hiv-immunocompromised-patients-with-toxoplasmosis-at-the-strasbourg-university-hospital-126345https://curecurrent.com/trials/trans-people-living-with-hiv-throughout-europe-126346https://curecurrent.com/trials/hiv-provider-intervention-to-address-intersectional-stigma-and-medical-mistrust-126347https://curecurrent.com/trials/trauma-intervention-to-optimize-prep-among-women-who-inject-drugs-126348https://curecurrent.com/trials/healer-initiated-hiv-counseling-and-testing-versus-standard-of-care-in-rural-south-africa-126349https://curecurrent.com/trials/low-dose-nivolumab-in-adults-living-with-hiv-on-antiretroviral-therapy-126350https://curecurrent.com/trials/determination-of-adequate-tuberculosis-regimen-in-patients-hospitalized-with-hiv-associated-severe-immune-suppression-126351https://curecurrent.com/trials/evaluation-of-a-home-based-community-health-worker-program-in-rural-eastern-cape-south-africa-126352https://curecurrent.com/trials/promoting-aging-and-thriving-with-hiv-126353https://curecurrent.com/trials/fih-lead-in-study-of-yaso-gel-followed-by-a-phase-1-randomized-double-blind-study-to-assess-safety-and-pharmacokinetics-126354https://curecurrent.com/trials/prep-at-a-syringe-services-program-126355https://curecurrent.com/trials/trauma-informed-resilience-based-telehealth-intervention-for-improving-hiv-prevention-and-hcv-care-for-persons-who-injec-126356https://curecurrent.com/trials/a-study-to-investigate-pharmacokinetics-safety-and-tolerability-of-long-acting-cabotegravir-plus-recombinant-human-hyalu-126357https://curecurrent.com/trials/ongoing-dynamic-choice-to-address-hiv-treatment-interruption-in-malawi-126358https://curecurrent.com/trials/estimation-of-the-prevalence-of-hiv-hepatitis-c-and-hepatitis-b-infection-among-detainees-in-the-n-mes-administrative-de-126359https://curecurrent.com/trials/acute-neural-and-immune-effects-of-alcohol-in-people-living-with-hiv-infection-126360https://curecurrent.com/trials/a-study-of-doravirine-islatravir-dor-isl-mk-8591a-for-the-treatment-of-human-immunodeficiency-virus-1-hiv-1-infection-in-126361https://curecurrent.com/trials/pre-exposure-prophylaxis-for-transgender-women-in-the-us-and-south-america-126362https://curecurrent.com/trials/cholesterol-and-inflammation-lowering-via-bempedoic-acid-an-acl-inhibiting-regimen-in-hiv-trial-clear-hiv-trial-126363https://curecurrent.com/trials/the-late-presenter-treatment-optimisation-study-126364https://curecurrent.com/trials/optimizing-screening-for-cervical-cancer-among-women-living-with-hiv-in-the-dominican-republic-126365https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-immunogenicity-of-the-v3-region-directed-immunogens-dv700p-rna-followed-by-dv701b1-1-126366https://curecurrent.com/trials/a-study-evaluating-implementation-strategies-for-the-delivery-of-cabotegravir-in-low-and-high-volume-prep-site-in-the-un-126367https://curecurrent.com/trials/strategies-to-improve-the-hiv-care-continuum-among-key-populations-in-india-126368https://curecurrent.com/trials/tnf-inhibitors-to-reduce-mortality-in-hiv-1-infected-patients-with-tuberculosis-meningitis-126369https://curecurrent.com/trials/safety-and-tolerability-of-1-month-daily-1hp-and-3-months-weekly-3hp-isoniazid-and-rifapentine-with-pharmacokinetics-of-126370https://curecurrent.com/trials/improving-hiv-prevention-among-heterosexual-men-seeking-sti-services-in-malawi-126371https://curecurrent.com/trials/rifapentine-and-isoniazid-tb-preventive-therapy-3hp-for-children-taking-dolutegravir-based-antiretroviral-treatment-dolp-126372https://curecurrent.com/trials/tb-screening-improves-preventive-therapy-uptake-in-pregnant-women-with-hiv-126373https://curecurrent.com/trials/decision-support-tool-to-integrate-prep-into-emergency-departments-126374https://curecurrent.com/trials/comparing-treatment-completion-of-daily-rifapentine-isoniazid-for-one-month-1hp-to-weekly-high-dose-rifapentine-isoniazi-126375https://curecurrent.com/trials/concordance-and-acceptability-of-self-screening-versus-screening-by-a-healthcare-professional-for-hpv-a-risk-factor-for-126376https://curecurrent.com/trials/confidential-care-and-adolescent-hiv-testing-126377https://curecurrent.com/trials/onsite-buprenorphine-treatment-at-syringe-exchange-programs-126378https://curecurrent.com/trials/safety-and-efficacy-of-dolutegravir-lamivudine-dtg-3tc-in-therapy-naive-human-immunodeficiency-virus-1-hiv-1-infected-ad-126379https://curecurrent.com/trials/therapeutic-drug-monitoring-to-optimize-antiretroviral-regimens-in-hiv-infected-women-who-want-to-breastfeed-126380https://curecurrent.com/trials/pre-exposure-prophylaxis-in-the-emergency-department-126381https://curecurrent.com/trials/gut-and-vaginal-microbiota-profile-study-for-hiv-women-126382https://curecurrent.com/trials/developing-a-dyadic-intervention-for-sexually-transmitted-infection-sti-hiv-prevention-in-youth-126383https://curecurrent.com/trials/incidence-of-hana-conditions-in-hiv-infected-individuals-126384https://curecurrent.com/trials/multi-component-intervention-to-train-providers-to-promote-prep-for-girls-and-women-in-the-deep-south-126385https://curecurrent.com/trials/intervention-to-improve-hiv-self-care-among-people-who-inject-drugs-126386https://curecurrent.com/trials/project-matter-intervention-to-improve-hiv-self-care-among-men-who-have-sex-with-men-msm-with-substance-use-disorders-126387https://curecurrent.com/trials/effect-of-high-intensity-exercise-to-attenuate-cognitive-function-limitations-and-train-exercise-habits-in-older-people-126388https://curecurrent.com/trials/cognitive-behavior-therapy-cbt-based-group-intervention-to-reduce-inflammation-in-older-people-with-hiv-126389https://curecurrent.com/trials/testing-a-gender-inclusive-hiv-prevention-program-126390https://curecurrent.com/trials/evaluation-of-problem-management-plus-in-pregnant-women-with-hiv-in-kenya-126391https://curecurrent.com/trials/optimization-of-cervical-cancer-screening-strategies-among-women-living-with-hiv-effectiveness-and-implementation-of-dec-126392https://curecurrent.com/trials/assessing-the-feasibility-of-economic-approaches-to-prevent-substance-abuse-among-adolescents-126393https://curecurrent.com/trials/pharmacokinetic-study-of-antiretroviral-drugs-and-related-drugs-during-and-after-pregnancy-126394https://curecurrent.com/trials/vaccines-in-a-time-of-dual-pandemic-covid-19-vaccine-in-people-with-hiv-126395https://curecurrent.com/trials/the-effect-of-dolutegravir-on-whole-body-insulin-sensitivity-lipid-and-endocrine-profile-in-healthy-volunteers-126396https://curecurrent.com/trials/using-cbpr-to-engage-hazardous-drinking-women-in-the-hiv-prevention-and-care-continuum-126397https://curecurrent.com/trials/computer-delivered-and-community-health-worker-supported-smoking-cessation-intervention-126398https://curecurrent.com/trials/a-study-to-investigate-if-long-acting-cabotegravir-cab-and-lenacapavir-len-injections-are-tolerable-and-acceptable-when-126399https://curecurrent.com/trials/evaluation-of-neuroinflammation-fnos-pet-ct-in-hiv-and-subjects-with-oud-and-healthy-controls-126400https://curecurrent.com/trials/the-opens-trial-offering-women-prep-aim-2-126401https://curecurrent.com/trials/hiv-1-subtype-specific-drug-resistance-in-patients-failing-dolutegravir-dtg-based-regimen-126402https://curecurrent.com/trials/couples-health-coop-plus-126403https://curecurrent.com/trials/peernaija-a-mobile-health-platform-incentivizing-medication-adherence-among-youth-living-with-hiv-in-nigeria-126404https://curecurrent.com/trials/developing-an-online-mindfulness-based-intervention-to-reduce-minority-stress-and-hiv-risk-among-young-adult-msm-aim-3-126405https://curecurrent.com/trials/text-messaging-to-promote-hiv-testing-in-gay-men-126406https://curecurrent.com/trials/the-sustain-2-study-sustained-hiv-treatment-for-adherence-after-interruption-in-care-126407https://curecurrent.com/trials/a-switch-to-doravirine-islatravir-dor-isl-in-participants-with-human-immunodeficiency-virus-type-1-hiv-1-who-are-virolog-126408https://curecurrent.com/trials/community-solutions-to-adolescent-research-consent-minor-consent-for-biomedical-hiv-research-126409https://curecurrent.com/trials/a-study-evaluating-the-safety-of-cal-1-lvsh5-c46-drug-product-in-hiv-1-infected-patient-with-high-risk-lymphoma-126410https://curecurrent.com/trials/developing-an-online-mindfulness-based-intervention-to-reduce-minority-stress-and-hiv-risk-among-young-adult-msm-126411https://curecurrent.com/trials/reducing-systemic-inflammation-in-people-on-antiretroviral-therapy-126412https://curecurrent.com/trials/pasteurized-donor-human-milk-for-hiv-exposed-infants-a-pilot-study-126413https://curecurrent.com/trials/supporting-trans-affirmation-relationships-and-sex-phase-3-126414https://curecurrent.com/trials/safety-reactogenicity-and-immunogenicity-of-hb-502-and-hb-501-versus-placebo-in-people-with-hiv-on-suppressive-art-126415https://curecurrent.com/trials/a-switch-to-doravirine-islatravir-dor-isl-in-participants-with-human-immunodeficiency-virus-type-1-hiv-1-who-are-virolog-126416https://curecurrent.com/trials/gathering-records-to-evaluate-antiretroviral-treatment-malawi-great-126417https://curecurrent.com/trials/gathering-records-to-evaluate-antiretroviral-treatment-south-africa-126418https://curecurrent.com/trials/criminal-justice-coordinated-transitional-care-126419https://curecurrent.com/trials/gathering-records-to-evaluate-antiretroviral-treatment-zambia-great-126420https://curecurrent.com/trials/positive-outcomes-improving-quality-126421https://curecurrent.com/trials/clinical-trial-to-evaluate-the-safety-and-immunogenicity-of-synthetic-dnas-encoding-np-gt8-and-il-12-with-or-without-a-t-126422https://curecurrent.com/trials/cross-disciplinary-hiv-integrated-mental-health-support-intervention-126423https://curecurrent.com/trials/scale-up-of-an-evidence-based-adolescent-transition-package-to-support-transitional-care-among-youth-living-with-hiv-126424https://curecurrent.com/trials/pain-inflammation-and-cannabis-in-hiv-126425https://curecurrent.com/trials/the-substance-abuse-treatment-to-hiv-care-ii-sat2hiv-ii-project-126426https://curecurrent.com/trials/pharmacokinetic-and-safety-study-of-a-90-day-intravaginal-ring-containing-tenofovir-126427https://curecurrent.com/trials/an-extension-protocol-for-subjects-who-successfully-completed-pro140-cd02-or-pro140-cd02-open-label-study-126428https://curecurrent.com/trials/intervention-to-reduce-implicit-bias-in-pharmacies-126429https://curecurrent.com/trials/syringe-service-based-telemedicine-and-social-network-driven-hiv-prevention-service-implementation-126430https://curecurrent.com/trials/feasibility-testing-a-meditation-app-for-youth-in-the-legal-system-126431https://curecurrent.com/trials/reaching-90-90-90-in-adolescents-in-zambia-using-all-our-skillz-126432https://curecurrent.com/trials/autologous-dendritic-cell-vaccine-in-hiv1-infection-126433https://curecurrent.com/trials/a-social-network-approach-for-improving-medication-assisted-treatment-and-hiv-prevention-and-medical-care-among-people-w-126434https://curecurrent.com/trials/suubi4prep-improving-prep-access-and-adherence-among-adolescent-girls-and-young-women-in-uganda-126435https://curecurrent.com/trials/improving-hiv-prevention-and-substance-use-post-sexual-assault-services-126436https://curecurrent.com/trials/oral-dronabinol-hiv-126437https://curecurrent.com/trials/cisgender-female-patients-who-start-on-long-acting-cabotegravir-for-prep-126438https://curecurrent.com/trials/enhancing-sexual-safety-couples-communication-and-hiv-testing-among-ymsm-126439https://curecurrent.com/trials/stepped-care-to-optimize-prep-effectiveness-in-pregnant-and-postpartum-women-126440https://curecurrent.com/trials/peer-prep-referral-hiv-self-test-delivery-for-prep-initiation-in-kenya-126441https://curecurrent.com/trials/peer-behavioral-activation-utilization-to-improve-substance-use-and-hiv-outcomes-in-people-receiving-long-acting-injecta-126442https://curecurrent.com/trials/prevention-and-risk-treatment-with-a-new-emphasis-on-relationships-126443https://curecurrent.com/trials/a-study-to-assess-the-safety-tolerability-and-pharmacokinetics-of-vh4011499-compared-to-placebo-in-adults-without-hiv-126444https://curecurrent.com/trials/comparison-of-dendritic-cell-based-therapeutic-vaccine-strategies-for-hiv-functional-cure-126445https://curecurrent.com/trials/a-study-to-assess-change-in-disease-activity-adverse-events-and-how-the-drug-moves-through-the-body-in-adult-participant-126446https://curecurrent.com/trials/pre-exposure-prophylaxis-implementation-in-central-eastern-european-countries-126447https://curecurrent.com/trials/implantable-long-acting-pre-exposure-prophylaxis-for-msm-126448https://curecurrent.com/trials/evaluating-the-effectiveness-of-a-mobile-hiv-prevention-app-to-increase-hiv-and-sexually-transmitted-infections-sti-test-126449https://curecurrent.com/trials/evaluating-a-clinical-decision-support-tool-for-antiretroviral-therapy-optimization-126450https://curecurrent.com/trials/yuva-sath-a-peer-led-behavioral-intervention-to-support-substance-use-treatment-and-hiv-prevention-among-young-people-wh-126451https://curecurrent.com/trials/accelerated-transcranial-magnetic-stimulation-tms-for-smoking-cessation-in-people-living-with-hiv-aids-plwha-126452https://curecurrent.com/trials/antiretroviral-improvement-among-medicaid-enrollees-126453https://curecurrent.com/trials/women-shine-addressing-syndemics-and-hiv-among-women-through-tech-based-peer-engagement-126454https://curecurrent.com/trials/a-study-to-investigate-the-antiviral-effect-safety-tolerability-and-pharmacokinetics-of-vh3739937-in-in-treatment-naive-126455https://curecurrent.com/trials/a-study-to-learn-about-the-effects-of-pneumococcal-vaccine-in-people-with-hiv-126456https://curecurrent.com/trials/bring-bpal2me-trial-comparing-nurse-led-rr-tb-treatment-to-physician-led-rr-tb-treatment-126457https://curecurrent.com/trials/study-of-the-safety-of-trogarzo-administered-as-an-undiluted-iv-push-or-an-intramuscular-injection-126458https://curecurrent.com/trials/simulation-training-for-labor-and-delivery-providers-to-address-hiv-stigma-during-childbirth-in-tanzania-126459https://curecurrent.com/trials/universal-basic-income-and-structural-racism-in-the-us-south-hiv-care-126460https://curecurrent.com/trials/happy-older-latinos-are-active-cognitive-decline-126461https://curecurrent.com/trials/hpv-vaccine-effectiveness-study-in-rwandan-women-living-with-hiv-126462https://curecurrent.com/trials/a-study-of-islatravir-isl-and-ulonivirine-ulo-once-weekly-qw-in-virologically-suppressed-adults-with-human-immunodeficie-126463https://curecurrent.com/trials/acute-effects-of-cannabis-on-cognition-and-mobility-in-older-hiv-infected-and-hiv-un-infected-women-126464https://curecurrent.com/trials/a-formative-study-to-explore-the-sensory-perceptions-of-vaginal-product-users-126465https://curecurrent.com/trials/cannabis-effects-on-antiretroviral-therapy-pharmacokinetics-and-neurotoxicity-126466https://curecurrent.com/trials/targeting-hiv-retention-and-improved-viral-load-through-engagement-thrive-126467https://curecurrent.com/trials/contingency-management-in-hiv-care-for-both-stimulant-use-art-adherence-126468https://curecurrent.com/trials/brief-acceptance-based-retention-intervention-for-newly-diagnosed-hiv-patients-126469https://curecurrent.com/trials/a-clinical-trial-to-evaluate-the-safety-and-immunogenicity-of-bg505-md39-3-bg505-md39-3-gp151-and-bg505-md39-3-gp151-cd4-126470https://curecurrent.com/trials/long-term-follow-up-for-the-detection-of-delayed-adverse-events-in-cal-1-recipients-126471https://curecurrent.com/trials/evaluating-the-safety-and-efficacy-of-long-acting-injectable-cabotegravir-compared-to-daily-oral-tdf-ftc-for-pre-exposur-126472https://curecurrent.com/trials/the-dreamer-girls-project-adaptation-of-sista-sihle-for-hiv-aids-and-substance-abuse-prevention-among-black-adolescent-g-126473https://curecurrent.com/trials/social-networks-and-methadone-maintenance-treatment-retention-and-antiretroviral-therapy-retention-in-tanzania-126474https://curecurrent.com/trials/computerized-substance-use-and-depression-screening-and-behavioral-treatment-in-hiv-primary-care-126475https://curecurrent.com/trials/evaluation-of-safety-and-immunogenicity-of-ad26-mos4-hiv-and-ch505-tf-chtrimer-combination-in-healthy-adults-126476https://curecurrent.com/trials/hiv-prevention-with-prep-among-people-on-opioid-replacement-therapy-126477https://curecurrent.com/trials/consent-for-use-of-stored-patient-specimens-for-future-testing-126478https://curecurrent.com/trials/proof-of-concept-clinical-pharmacology-trial-for-hiv-antigen-presentation-therapeutic-biologic-mix-126479https://curecurrent.com/trials/an-extension-of-protocol-pro-140-cd01-study-126480https://curecurrent.com/trials/a-pilot-study-of-metformin-to-reduce-cerebrovascular-dysfunction-in-participants-with-hiv-and-metabolic-syndrome-126481https://curecurrent.com/trials/hiv-prevention-smartphone-game-trial-126482https://curecurrent.com/trials/podcasting-hiv-prevention-within-african-american-communities-126483https://curecurrent.com/trials/a-trial-of-positively-smoke-free-group-therapy-for-hiv-infected-smokers-126484https://curecurrent.com/trials/bringing-optimised-covid-19-vaccine-schedules-to-immunocompromised-populations-boost-ic-an-adaptive-randomised-controlle-126485https://curecurrent.com/trials/insti-s-for-the-management-of-hiv-associated-tb-126486https://curecurrent.com/trials/comparison-of-the-body-roundness-index-and-a-body-shape-index-with-body-fat-and-visceral-fat-in-people-living-with-hiv-126487https://curecurrent.com/trials/tulane-abdominal-transplant-institute-tati-of-solid-organ-transplantation-of-hiv-positive-recipients-from-hiv-positive-d-126488https://curecurrent.com/trials/pd-1-inhibition-to-determine-cns-reservoir-of-hiv-infection-126489https://curecurrent.com/trials/3bnc117-and-10-1074-in-art-treated-individuals-126490https://curecurrent.com/trials/low-dead-space-injecting-equipment-distribution-program-for-people-who-inject-drugs-in-low-and-middle-income-countries-126491https://curecurrent.com/trials/prep-intervention-in-prince-george-s-county-maryland-126492https://curecurrent.com/trials/experiential-hiv-testing-increasing-testing-related-knowledge-and-practice-and-reduce-stigma-toward-hiv-of-nurses-126493https://curecurrent.com/trials/physical-activity-and-people-living-with-hiv-in-new-york-city-126494https://curecurrent.com/trials/testing-a-barbershop-based-hiv-prevention-initiative-among-men-126495https://curecurrent.com/trials/proof-of-concept-treatment-study-of-orally-administered-vh4004280-or-vh4011499-in-hiv-1-infected-adults-126496https://curecurrent.com/trials/retrospective-review-of-dtg-3tc-versus-bic-f-taf-across-a-multi-clinic-infectious-disease-organization-in-southeast-unit-126497https://curecurrent.com/trials/testing-strategies-for-couple-engagement-in-pmtct-and-family-health-in-kenya-126498https://curecurrent.com/trials/bone-mineral-density-bmd-in-hiv-infection-126499https://curecurrent.com/trials/adaptation-and-implementation-of-project-encuentro-in-the-u-s-mexico-border-126500https://curecurrent.com/trials/clinical-trial-to-evaluate-the-safety-and-immunogenicity-of-a-priming-regimen-of-426c-mod-core-c4b-followed-by-hxb2-wt-c-126501https://curecurrent.com/trials/investigating-point-of-care-diagnostics-for-sexually-transmitted-infections-and-antimicrobial-resistance-in-primary-care-126502https://curecurrent.com/trials/microbiota-footprint-and-frailty-phenotype-in-virologically-suppressed-people-living-with-hiv-126503https://curecurrent.com/trials/impact-of-recombinant-human-growth-hormone-on-hiv-persistence-126504https://curecurrent.com/trials/hiv-to-hiv-transplant-at-mgh-126505https://curecurrent.com/trials/evaluating-the-safety-and-immunogenicity-of-an-hiv-1-gp41-mper-656-liposome-vaccine-in-healthy-hiv-uninfected-adult-part-126506https://curecurrent.com/trials/evolution-of-hiv-reservoir-inflammation-and-microbiota-footprint-of-plwh-switching-to-long-acting-injectable-treatment-c-126507https://curecurrent.com/trials/peers-plus-mobile-app-for-treatment-in-hiv-126508https://curecurrent.com/trials/adherence-connection-for-counseling-education-and-support-access-ii-126509https://curecurrent.com/trials/telehealth-as-a-modality-to-increase-the-uptake-of-prep-services-in-black-and-latino-e-prep-126510https://curecurrent.com/trials/study-of-people-with-hiv-infection-who-have-high-viral-loads-despite-combination-antiretroviral-therapy-126511https://curecurrent.com/trials/prevention-icona-dedicated-ensemble-126512https://curecurrent.com/trials/safety-and-impact-of-dasatinib-on-viral-persistence-and-inflammation-in-people-with-hiv-under-antiretroviral-treatment-126513https://curecurrent.com/trials/expanding-medication-assisted-therapies-in-central-asia-126514https://curecurrent.com/trials/diagnostic-accuracy-of-cad4tb-and-c-reactive-protein-assay-as-triage-tests-for-pulmonary-tuberculosis-126515https://curecurrent.com/trials/family-connections-cluster-rct-in-zambia-126516https://curecurrent.com/trials/estamos-juntos-we-are-together-improving-hiv-care-delivery-by-capacitating-health-care-providers-126517https://curecurrent.com/trials/implementation-and-effectiveness-of-physical-activity-to-prevent-disability-in-hiv-infected-adults-older-than-50-from-c-126518https://curecurrent.com/trials/mindfulness-and-behavior-change-to-improve-cardiovascular-health-of-older-people-with-hiv-126519https://curecurrent.com/trials/empirical-treatment-against-cytomegalovirus-and-tuberculosis-in-hiv-infected-infants-with-severe-pneumonia-126520https://curecurrent.com/trials/impact-of-nursing-involvement-on-implementation-of-hiv-prevention-services-126521https://curecurrent.com/trials/striving-towards-empowerment-and-medication-adherence-r01-126522https://curecurrent.com/trials/the-effects-of-ageing-on-the-pharmacokinetic-and-clinical-observations-in-people-over-fifty-126523https://curecurrent.com/trials/zoledronic-acid-for-the-prevention-of-tdf-sparing-art-induced-bone-mass-density-loss-in-treatment-naive-hiv-positive-ind-126524https://curecurrent.com/trials/personalized-prevention-for-couples-a-16-month-digital-rct-126525https://curecurrent.com/trials/improving-the-hiv-prep-cascade-using-an-intervention-for-healthcare-providers-126526https://curecurrent.com/trials/elimisha-hpv-human-papillomavirus-126527https://curecurrent.com/trials/a-waiting-room-delivered-video-to-enhance-clinical-outcomes-among-persons-living-with-hiv-126528https://curecurrent.com/trials/development-of-ingestible-biosensors-to-enhance-prep-adherence-in-substance-users-prepsteps-126529https://curecurrent.com/trials/the-impact-of-insomnia-on-pain-in-hiv-126530https://curecurrent.com/trials/impact-of-a-single-versus-multiple-visits-on-the-cervical-cancer-screening-completeness-feasibility-and-acceptability-am-126531https://curecurrent.com/trials/mental-health-support-for-transgender-and-gender-expansive-individuals-126532https://curecurrent.com/trials/genital-tract-infections-the-vaginal-microbiome-and-gestational-age-at-birth-among-pregnant-women-in-south-africa-126533https://curecurrent.com/trials/building-mobile-hiv-prevention-and-mental-health-support-in-low-resource-settings-126534https://curecurrent.com/trials/the-eswatini-study-on-neurocognitive-performance-in-adolescents-living-with-hiv-126535https://curecurrent.com/trials/integrated-care-delivery-of-hiv-prevention-and-treatment-in-agyw-in-zambia-126536https://curecurrent.com/trials/switch-to-dolutegravir-plus-lamivudine-dual-therapy-in-transgender-women-living-with-hiv-on-virologically-suppressive-an-126537https://curecurrent.com/trials/evaluating-a-combination-of-immune-based-therapies-to-achieve-a-remission-of-hiv-infection-126538https://curecurrent.com/trials/prevention-and-treatment-of-patient-before-during-and-after-covid-19-infection-126539https://curecurrent.com/trials/doxy-post-exposure-prophylaxis-126540https://curecurrent.com/trials/effect-of-omega-3-supplementation-on-pregnant-outcomes-and-inflammation-markers-of-women-infected-with-hiv-using-antiret-126541https://curecurrent.com/trials/ndovu-rct-investing-the-optimal-management-of-dolutegravir-resistance-126542https://curecurrent.com/trials/welcoming-by-design-pilot-reducing-structural-stigma-by-changing-clinic-systems-and-architectural-design-126543https://curecurrent.com/trials/camellia-cohort-a-longitudinal-study-to-understand-sexual-health-and-prevention-among-women-in-alabama-126544https://curecurrent.com/trials/evaluation-of-doravirine-lamivudine-tenofovir-disoproxil-fumarate-delstrigo-as-a-new-strategy-for-non-occupational-post-126545https://curecurrent.com/trials/individualized-antiretroviral-therapy-126546https://curecurrent.com/trials/severe-impairment-of-solute-free-water-clearance-in-patients-with-hiv-infection-126547https://curecurrent.com/trials/corticosteroids-for-pjp-in-non-hiv-immunocompromised-adults-126548https://curecurrent.com/trials/optimizing-care-for-challenging-people-living-with-hiv-126549https://curecurrent.com/trials/exploring-long-term-risks-and-sti-prevalence-in-pre-exposure-prophylaxis-users-in-gironde-france-126550https://curecurrent.com/trials/investigating-the-optimal-management-of-dolutegravir-resistance-126551https://curecurrent.com/trials/immune-response-of-shingrix-vaccine-in-people-living-with-hiv-50-y-o-compared-to-age-matched-controls-126552https://curecurrent.com/trials/contingency-management-for-cannabis-use-for-persons-with-hiv-126553https://curecurrent.com/trials/easy-tests-evaluation-of-the-acceptability-of-pre-exposure-prophylaxis-prep-among-men-who-have-sex-with-men-msm-who-acce-126554https://curecurrent.com/trials/preparing-family-planning-clinics-to-streamline-integration-of-hiv-prevention-services-for-young-women-in-kenya-126555https://curecurrent.com/trials/evaluating-the-use-of-pitavastatin-to-reduce-the-risk-of-cardiovascular-disease-in-hiv-infected-adults-126556https://curecurrent.com/trials/a-clinical-trial-to-evaluate-the-safety-and-immunogenicity-of-glycan-trimmed-hiv-1-nanoparticle-vaccine-uvax-1107-follow-126557https://curecurrent.com/trials/safety-and-pharmacokinetics-of-dolutegravir-in-pregnant-hiv-mothers-and-their-neonates-a-pilot-study-126558https://curecurrent.com/trials/fecal-microbiota-translantation-fmt-to-reduce-inflammation-in-plwh-the-gutsy-pilot-study-126559https://curecurrent.com/trials/reducing-mortality-in-adults-with-advanced-hiv-disease-revive-126560https://curecurrent.com/trials/stick2prep-cisgender-women-and-trans-individuals-126561https://curecurrent.com/trials/saroglitazar-magnesium-4-mg-for-nonalcoholic-fatty-liver-disease-nafld-in-people-living-with-hiv-in-the-us-126562https://curecurrent.com/trials/safety-and-pk-multi-dose-study-of-taf-evg-vaginal-insert-126563https://curecurrent.com/trials/evaluating-the-safety-and-immunogenicity-of-hiv-1-bg505-sosip-664-gp140-with-tlr-agonist-and-or-alum-adjuvants-in-health-126564https://curecurrent.com/trials/a-clinical-trial-to-evaluate-the-safety-and-immunogenicity-of-synthetic-dnas-encoding-a-native-like-hiv-env-trimer-and-i-126565https://curecurrent.com/trials/impact-of-covid-19-on-syphilis-126566https://curecurrent.com/trials/functional-imaging-reserve-in-neurohiv-126567https://curecurrent.com/trials/hiv-treatment-adherence-dose-determination-trial-126568https://curecurrent.com/trials/intervention-to-improve-hiv-care-retention-by-addressing-stigma-stigmatized-environments-126569https://curecurrent.com/trials/myprep-plus-development-and-pilot-testing-of-novel-preexposure-prophylaxis-decision-support-tools-for-transgender-women-126570https://curecurrent.com/trials/study-of-the-prevalence-of-transmitted-hiv-1-resistance-viral-diversity-and-cluster-identification-in-patients-at-the-ti-126571https://curecurrent.com/trials/prevalence-and-predictors-of-neurocognitive-impairment-among-hiv-infected-patients-126572https://curecurrent.com/trials/examining-the-effects-of-theory-based-education-on-individuals-sexual-behavior-126573https://curecurrent.com/trials/safety-and-immunogenicity-of-hiv-1-vaccines-c62-m4-or-c1c62-m3m4-in-persons-with-hiv-1-suppressed-on-art-126574https://curecurrent.com/trials/hpv-vaccination-in-hiv-infected-and-hiv-uninfected-adolescents-in-eswatini-126575https://curecurrent.com/trials/hiv-patients-with-chronic-hepatitis-c-genotype-1-infection-who-failed-previously-to-peginterferon-ribavirin-126576https://curecurrent.com/trials/tel-me-box-testing-a-new-real-time-strategies-for-monitoring-hiv-medication-adherence-in-india-126577https://curecurrent.com/trials/trauma-informed-care-for-youth-with-hiv-in-memphis-126578https://curecurrent.com/trials/efficacy-safety-and-tolerability-study-of-long-acting-cabotegravir-plus-long-acting-rilpivirine-cab-la-rpv-la-in-human-i-126579https://curecurrent.com/trials/a-study-of-the-safety-and-pharmacokinetics-of-a-human-monoclonal-antibody-vrchivmab0115-00-ab-vrc01-23ls-administered-in-126580https://curecurrent.com/trials/efficacy-safety-and-tolerability-of-switching-to-a-two-drug-regimen-with-dtg-3tc-compared-to-maintaining-a-three-drug-re-126581https://curecurrent.com/trials/phase-i-open-label-dose-escalation-study-to-evaluate-safety-of-ihivarna-01-in-chronically-hiv-infected-patients-126582https://curecurrent.com/trials/adapting-an-evidence-based-intervention-to-improve-hiv-testing-and-prep-uptake-in-vietnam-126583https://curecurrent.com/trials/a-comprehensive-hiv-prevention-package-for-south-african-adolescent-girls-and-young-women-imara-sa-126584https://curecurrent.com/trials/development-and-evaluation-of-a-prep-decision-aid-for-women-seeking-domestic-violence-services-in-baltimore-126585https://curecurrent.com/trials/schooling-income-and-hiv-risk-in-malawi-126586https://curecurrent.com/trials/a-study-to-evaluate-the-performance-of-insti-hiv-self-test-when-performed-by-unobserved-intended-users-in-the-us-126587https://curecurrent.com/trials/the-quality-of-life-and-viral-control-effect-of-aids-patients-after-long-acting-injection-of-cabotegravir-and-rilpivirin-126588https://curecurrent.com/trials/positivelinks-mhealth-for-dc-cohort-126589https://curecurrent.com/trials/integrating-u-u-into-hiv-counseling-in-south-africa-126590https://curecurrent.com/trials/wellness-intervention-for-smoking-and-hiv-126591https://curecurrent.com/trials/testing-an-integrated-bio-behavioral-primary-hiv-prevention-intervention-among-high-risk-people-who-use-drugs-126592https://curecurrent.com/trials/serological-responses-to-adjuvanted-versus-non-adjuvanted-influenza-vaccines-among-people-with-hiv-a-randomized-clinical-126593https://curecurrent.com/trials/description-of-real-world-antiviral-effectiveness-and-sustainability-of-the-2-drug-regimen-dolutegravir-lamivudine-in-un-126594https://curecurrent.com/trials/improving-the-reproductive-health-of-families-126595https://curecurrent.com/trials/pilot-mobile-medical-unit-study-for-i-m-fully-empowered4her-126596https://curecurrent.com/trials/validation-of-a-multidimensional-scale-for-the-detection-of-health-needs-in-people-with-hiv-126597https://curecurrent.com/trials/brentuximab-vedotin-and-combination-chemotherapy-in-treating-patients-with-stage-ii-iv-hiv-associated-hodgkin-lymphoma-126598https://curecurrent.com/trials/supporting-tailored-and-responsive-prep-in-rural-north-carolina-126599https://curecurrent.com/trials/post-exposure-prophylaxis-in-health-care-workers-126600https://curecurrent.com/trials/acceptability-and-feasibility-of-simultaneous-screening-for-viral-hepatitis-b-c-and-hiv-among-drug-users-and-vulnerable-126601https://curecurrent.com/trials/healthy-mothers-an-intervention-to-support-perinatal-women-living-with-hiv-in-kenya-126602https://curecurrent.com/trials/m-suubi-a-multi-level-integrated-intervention-to-reduce-the-impact-of-hiv-stigma-126603https://curecurrent.com/trials/observational-study-of-hiv-deceased-donor-transplant-for-hiv-recipients-126604https://curecurrent.com/trials/cd34-non-malignant-stem-cell-selection-for-patients-receiving-allogeneic-stem-cell-transplantation-126605https://curecurrent.com/trials/enhanced-virologic-monitoring-for-pregnant-and-postpartum-women-with-hiv-126606https://curecurrent.com/trials/anal-cancer-prevention-in-high-risk-categories-of-men-who-have-sex-with-men-126607https://curecurrent.com/trials/efficacy-trial-of-life-simulation-game-to-routinize-adolescent-hiv-testing-126608https://curecurrent.com/trials/a-cognitive-behavioral-therapy-group-intervention-to-increase-hiv-testing-and-prep-use-among-latinx-sexual-minority-men-126609https://curecurrent.com/trials/smartmanage-stress-management-for-hiv-cancer-survivors-126610https://curecurrent.com/trials/itransition-development-126611https://curecurrent.com/trials/morbidity-mortality-and-risk-factors-of-mpox-in-hiv-negative-high-risk-sexual-health-clinic-attenders-and-people-living-126612https://curecurrent.com/trials/choice-architecture-based-tb-preventive-therapy-prescribing-126613https://curecurrent.com/trials/switch-to-bictegravir-emtricitabine-tenofovir-alafenamide-bic-f-taf-after-renal-transplant-126614https://curecurrent.com/trials/assessing-the-feasibility-of-coach-mpilo-for-men-with-tb-and-hiv-126615https://curecurrent.com/trials/randomized-open-label-safety-trial-of-dapivirine-vaginal-ring-and-oral-truvada-use-in-pregnancy-126616https://curecurrent.com/trials/mesenchymal-stem-cells-treatment-for-aids-patients-at-late-stage-126617https://curecurrent.com/trials/project-vuselela-feasibility-126618https://curecurrent.com/trials/substance-use-and-hiv-action-for-reentry-and-engagement-126619https://curecurrent.com/trials/implementation-and-effects-of-nishauri-on-hiv-treatment-outcomes-among-men-126620https://curecurrent.com/trials/safety-and-effects-of-using-prime-boost-hivis-dna-and-mva-cmdr-vaccine-regimens-with-or-without-toll-like-receptor-4-ago-126621https://curecurrent.com/trials/secondary-hiv-prevention-and-adherence-among-hiv-infected-drug-users-126622https://curecurrent.com/trials/contributing-factors-for-poor-hiv-treatment-response-in-children-with-tb-hiv-coinfection-126623https://curecurrent.com/trials/pharmacist-led-intervention-to-improve-tb-treatment-adherence-126624https://curecurrent.com/trials/couple-based-motivational-interviewing-with-mobile-breathalyzers-to-reduce-alcohol-use-in-south-africa-126625https://curecurrent.com/trials/re-engagement-at-discharge-2-126626https://curecurrent.com/trials/hpv-based-screen-and-treat-demonstration-project-in-lilongwe-126627https://curecurrent.com/trials/a-couples-based-intervention-for-transgender-women-and-their-partners-126628https://curecurrent.com/trials/community-home-based-education-screening-services-strategy-to-increase-cervical-cancer-control-access-for-hiv-positive-w-126629https://curecurrent.com/trials/increasing-prep-awareness-and-demand-among-black-cisgender-women-126630https://curecurrent.com/trials/changes-in-immunologic-parameters-following-the-addition-of-fostemsavir-in-virologically-suppressed-immunologic-non-resp-126631https://curecurrent.com/trials/mytpill-a-novel-strategy-to-monitor-antiretroviral-adherence-among-hiv-prescription-opioid-users-126632https://curecurrent.com/trials/becoming-hiv-exposed-uninfected-children-born-to-hiv-positive-mothers-followed-at-bichat-claude-bernard-hospital-126633https://curecurrent.com/trials/viral-load-triggered-art-care-in-lesotho-126634https://curecurrent.com/trials/letermovir-in-art-treated-hiv-infected-persons-126635https://curecurrent.com/trials/the-less-is-more-study-126636https://curecurrent.com/trials/developing-a-trauma-focused-intervention-for-older-adults-living-with-hiv-126637https://curecurrent.com/trials/cost-effectiveness-of-different-antiretroviral-treatment-in-patients-hiv-naive-126638https://curecurrent.com/trials/le-kip-kip-a-campaign-to-change-social-norms-and-build-sustainable-demand-for-prep-among-women-in-south-africa-126639https://curecurrent.com/trials/hiv-vaccine-in-hiv-uninfected-adults-126640https://curecurrent.com/trials/dolutegravir-lamivudine-for-na-ve-hiv-infected-patients-with-200-cd4-mm3-126641https://curecurrent.com/trials/first-time-in-human-ftih-study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-pk-of-vh4004280-in-healthy-parti-126642https://curecurrent.com/trials/hiv-prevention-and-care-interventions-for-youth-in-uganda-126643https://curecurrent.com/trials/odyssey-penta-20-126644https://curecurrent.com/trials/implementation-and-delivery-of-cabotegravir-long-acting-injection-for-prep-in-a-community-pharmacy-setting-126645https://curecurrent.com/trials/testing-of-the-smartphone-app-to-enhance-hiv-prevention-cascade-among-malaysian-msm-126646https://curecurrent.com/trials/vr-mindfulness-for-people-with-hiv-and-substance-use-126647https://curecurrent.com/trials/testing-of-the-jomprep-app-for-hiv-prevention-among-malaysian-msm-126648https://curecurrent.com/trials/acceptability-feasibility-and-preliminary-impact-of-a-web-based-hiv-prevention-toolkit-with-cisgender-male-couples-in-li-126649https://curecurrent.com/trials/rectal-insert-taf-evg-pre-exposure-prophylaxis-rite-prep-study-126650https://curecurrent.com/trials/pan-viral-screening-and-linkage-to-care-among-gbmsm-and-trans-women-in-spain-126651https://curecurrent.com/trials/supporting-oral-and-long-acting-prep-decision-making-among-pregnant-women-in-lilongwe-malawi-126652https://curecurrent.com/trials/dor-tdf-3tc-switch-with-m184v-i-in-people-with-controlled-hiv-drive-off-road-126653https://curecurrent.com/trials/onboarding-positives-and-prep-users-to-engage-negatives-oppen-peer-driven-education-to-link-ymsm-of-color-to-prep-126654https://curecurrent.com/trials/imiquimod-fluorouracil-or-observation-in-treating-hiv-positive-patients-with-high-grade-anal-squamous-skin-lesions-126655https://curecurrent.com/trials/integrating-depression-care-into-hiv-services-for-older-people-with-hiv-using-a-stepped-care-task-sharing-approach-126656https://curecurrent.com/trials/safety-efficacy-of-dual-therapy-with-raltegravir-lamivudine-126657https://curecurrent.com/trials/b-enhancement-of-hbv-vaccination-in-persons-living-with-hiv-bee-hive-evaluation-of-heplisav-b-126658https://curecurrent.com/trials/project-orleu-reducing-intersectional-and-hiv-stigma-among-health-care-providers-and-high-risk-women-who-use-drugs-in-ka-126659https://curecurrent.com/trials/using-the-ending-self-stigma-intervention-to-reduce-internalized-stigma-among-people-living-with-hiv-who-use-substances-126660https://curecurrent.com/trials/phase-iv-a-clinical-trial-to-assess-safety-and-convenience-of-the-change-from-dtg-3tc-to-bic-ftc-taf-in-people-with-hiv-126661https://curecurrent.com/trials/virological-and-immunological-safety-of-a-dose-reduction-strategy-antiretroviral-regimen-with-efavirenz-tenofovir-emtric-126662https://curecurrent.com/trials/dtg-3tc-vs-bic-ftc-taf-maintenance-therapy-in-people-living-with-hiv-126663https://curecurrent.com/trials/the-university-of-zimbabwe-college-of-health-science-uz-chs-birth-cohort-study-126664https://curecurrent.com/trials/simplification-study-of-hiv-1-infected-patients-with-virological-suppression-under-the-combination-of-lamivudine-150-mg-126665https://curecurrent.com/trials/safety-and-pharmacokinetics-of-oral-islatravir-mk-8591-once-monthly-in-participants-at-low-risk-of-human-immunodeficienc-126666https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-a-rilpivarine-based-antiretroviral-tratment-regimen-in-hiv-infected-patient-126667https://curecurrent.com/trials/towards-a-functional-cure-for-hbv-the-commit-cohort-study-126668https://curecurrent.com/trials/single-dose-islatravir-in-moderate-hepatic-impairment-mk-8591-030-126669https://curecurrent.com/trials/safety-and-immunogenicity-of-a-mycobacterium-tuberculosis-vaccine-m72-as01e-in-participants-with-well-controlled-hiv-126670https://curecurrent.com/trials/the-blued-combination-hiv-prevention-pilot-study-in-china-126671https://curecurrent.com/trials/treatment-with-rosuvastatin-versus-switching-pi-protease-inhibitor-in-patients-hiv-with-high-cholesterol-levels-126672https://curecurrent.com/trials/a-study-to-evaluate-the-effects-of-cenicriviroc-mesylate-on-arterial-inflammation-in-people-living-with-hiv-126673https://curecurrent.com/trials/can-insti-associated-weight-gain-be-halted-or-reversed-with-a-switch-to-doravirine-lamivudine-tenofovir-df-126674https://curecurrent.com/trials/gsk3739937-first-time-in-human-ftih-study-in-healthy-volunteers-126675https://curecurrent.com/trials/improving-perinatal-outcomes-among-kenyan-pregnant-women-with-an-integrated-sti-testing-model-126676https://curecurrent.com/trials/hiv-and-parasitic-infection-hapi-study-126677https://curecurrent.com/trials/improving-uptake-and-adherence-to-hiv-prevention-services-with-pre-exposure-prophylaxis-prep-hiv-self-testing-and-adhere-126678https://curecurrent.com/trials/acupuncture-therapy-vs-chiropractor-group-therapy-to-reduce-anxiety-and-depression-126679https://curecurrent.com/trials/community-based-peer-delivered-prep-for-female-sex-workers-in-rural-uganda-the-peers-for-prep-p4p-study-126680https://curecurrent.com/trials/implementation-of-out-of-hospital-administration-of-the-long-acting-cabotegravir-rilpivirine-126681https://curecurrent.com/trials/using-smart-phone-technology-to-support-hiv-medication-refill-adherence-in-virginia-126682https://curecurrent.com/trials/a-trial-of-anti-cd4-antibody-ub-421-in-combination-with-optimized-background-antiretroviral-therapy-in-patients-with-mul-126683https://curecurrent.com/trials/a-study-to-evaluate-the-performance-usability-and-result-interpretation-of-insti-hiv-self-test-126684https://curecurrent.com/trials/safety-and-acceptability-study-of-non-occupational-prophylaxis-pep-following-potential-exposure-to-hiv-126685https://curecurrent.com/trials/screening-for-anal-cancer-and-precancer-in-women-with-hiv-sanca-126686https://curecurrent.com/trials/evaluating-hitsystem-2-1-to-improve-viral-suppression-in-kenya-126687https://curecurrent.com/trials/partner-services-pre-exposure-prophylaxis-ps-prep-126688https://curecurrent.com/trials/a-trauma-informed-intervention-for-the-newly-hiv-diagnosed-126689https://curecurrent.com/trials/behavioral-activation-nutrition-and-activity-intervention-126690https://curecurrent.com/trials/the-role-of-the-gastrointestinal-associated-lymphoid-tissue-in-the-cure-of-hiv-infection-126691https://curecurrent.com/trials/dot-diary-mobile-app-for-pre-exposure-prophylaxis-adherence-in-young-men-126692https://curecurrent.com/trials/linkpositively-a-technology-delivered-peer-navigation-and-social-networking-intervention-to-improve-hiv-care-126693https://curecurrent.com/trials/managed-problem-solving-for-art-adherence-and-hiv-care-retention-delivered-by-community-health-workers-126694https://curecurrent.com/trials/implementation-and-effectiveness-of-a-psychosocial-intervention-among-registered-people-living-with-hiv-hiv-patients-at-126695https://curecurrent.com/trials/integrating-tobacco-use-cessation-into-hiv-care-and-treatment-in-kisumu-county-kenya-126696https://curecurrent.com/trials/simplification-from-tenofovir-plus-lamivudine-or-emtricitabine-plus-ritonavir-boosted-protease-inhibitor-to-ritonavir-bo-126697https://curecurrent.com/trials/zenyth-motivational-interviewing-based-telehealth-intervention-for-bacterial-sexually-transmitted-infection-screening-126698https://curecurrent.com/trials/mhealth-app-for-engagement-in-care-among-youth-living-with-hiv-126699https://curecurrent.com/trials/east-africa-point-of-care-viral-load-study-126700https://curecurrent.com/trials/optimizing-prevention-and-care-for-pregnant-and-postpartum-adolescent-girls-and-young-women-with-hiv-in-tanzania-126701https://curecurrent.com/trials/analysis-of-cerebrospinal-fluid-in-patients-with-cerebral-toxoplasmosis-at-chsd-2004-2024-126702https://curecurrent.com/trials/prep-readiness-interventions-for-supporting-motivation-126703https://curecurrent.com/trials/vh4524184-proof-of-concept-in-treatment-na-ve-adults-living-with-hiv-1-126704https://curecurrent.com/trials/adolescent-master-protocol-for-participants-18-years-of-age-and-older-amp-up-126705https://curecurrent.com/trials/our-family-our-future-acceptability-and-feasibility-study-of-a-family-prevention-program-for-hiv-risk-and-depression-126706https://curecurrent.com/trials/adolescent-master-protocol-126707https://curecurrent.com/trials/adolescent-master-protocol-for-participants-18-years-of-age-or-older-lite-126708https://curecurrent.com/trials/study-to-evaluate-emtricitabine-tenofovir-alafenamide-f-taf-in-human-immunodeficiency-virus-1-hiv-1-infected-children-an-126709https://curecurrent.com/trials/electronic-sbi-rt-for-msm-in-argentina-126710https://curecurrent.com/trials/surveillance-monitoring-for-art-toxicities-study-in-hiv-uninfected-children-born-to-hiv-infected-women-126711https://curecurrent.com/trials/optimal-management-of-hiv-infected-adults-at-risk-for-kidney-complications-in-nigeria-126712https://curecurrent.com/trials/come-as-you-are-assessing-the-efficacy-of-a-nurse-case-management-hiv-prevention-and-care-intervention-among-homeless-yo-126713https://curecurrent.com/trials/multiplo-near-patient-non-hcp-study-126714https://curecurrent.com/trials/post-release-retention-in-hiv-care-for-ex-inmates-in-south-africa-126715https://curecurrent.com/trials/effect-of-dolutegravir-compared-with-darunavir-cobicistat-on-the-severity-of-neuropsychiatric-effects-al-12-weeks-in-ant-126716https://curecurrent.com/trials/empowering-knowledge-self-testing-resilience-through-innovative-methods-for-hiv-126717https://curecurrent.com/trials/bone-and-body-comp-a-sub-study-of-the-second-line-study-126718https://curecurrent.com/trials/can-resistance-enhance-selection-of-treatment-crest-126719https://curecurrent.com/trials/safety-tolerability-and-effectiveness-of-dtg-3tc-vs-bic-taf-ftc-in-pwh-without-antiretroviral-experience-126720https://curecurrent.com/trials/cognitive-impairment-in-older-hiv-infected-patients-65-years-old-126721https://curecurrent.com/trials/phase-iib-trial-of-recombinant-novel-coronavirus-vaccine-ad5-ncov-in-adults-18-years-of-age-and-older-living-with-hiv-126722https://curecurrent.com/trials/evaluating-next-generation-lam-assays-and-molecular-diagnostics-poc-and-near-poc-for-the-diagnosis-of-tb-among-people-wi-126723https://curecurrent.com/trials/1-1-comparison-of-the-pocket-colposcope-in-kenya-126724https://curecurrent.com/trials/piloting-eye-movement-desensitization-and-reprocessing-emdr-therapy-in-people-living-with-hiv-and-trauma-126725https://curecurrent.com/trials/integrated-prevention-of-hiv-risk-and-intimate-partner-violence-among-adolescents-in-south-africa-126726https://curecurrent.com/trials/stigma-and-a-shared-decision-aid-126727https://curecurrent.com/trials/supporting-young-women-s-reproductive-health-by-harnessing-prosociality-among-drug-shopkeepers-126728https://curecurrent.com/trials/a-study-to-evaluate-the-pharmacokinetics-safety-and-tolerability-of-cabotegravir-ultra-long-acting-cab-ula-following-swi-126729https://curecurrent.com/trials/brief-interventions-in-the-emergency-department-for-alcohol-and-hiv-sexual-risk-126730https://curecurrent.com/trials/ultra-curto-ultra-short-tb-prevention-therapy-126731https://curecurrent.com/trials/simplified-isoniazid-preventive-therapy-strategy-to-reduce-tb-burden-126732https://curecurrent.com/trials/schools-championing-safe-south-africa-126733https://curecurrent.com/trials/clinical-trial-to-evaluate-the-effect-of-raltegravir-intensification-1-200-mg-qd-on-the-gut-microbiota-of-chronically-hi-126734https://curecurrent.com/trials/feminizing-hormone-therapy-and-the-rectal-mucosa-immune-environment-in-transgender-women-126735https://curecurrent.com/trials/alignment-of-prep-use-with-hiv-risk-in-young-women-and-men-126736https://curecurrent.com/trials/leukotriene-a4-hydrolase-stratified-trial-of-adjunctive-corticosteroids-for-hiv-uninfected-adults-with-tuberculous-menin-126737https://curecurrent.com/trials/v-psf-m-for-tobacco-cessation-in-hiv-care-in-india-126738https://curecurrent.com/trials/piloting-a-smartphone-app-to-improve-treatment-adherence-among-south-african-adolescents-living-with-hiv-126739https://curecurrent.com/trials/zinc-effect-on-inflammation-and-cardiovascular-risk-in-hiv-126740https://curecurrent.com/trials/uptake-and-adherence-to-daily-oral-prep-as-a-primary-prevention-strategy-for-young-african-women-a-vanguard-study-126741https://curecurrent.com/trials/vaccine-immunity-and-inflammation-in-the-aging-person-living-with-hiv-126742https://curecurrent.com/trials/role-of-viral-reservoir-immune-activation-and-depletion-in-persistent-viremia-persistent-viremia-in-people-living-with-h-126743https://curecurrent.com/trials/nevirapine-lamivudine-for-hiv-maintenance-therapy-126744https://curecurrent.com/trials/tb-screening-improves-preventive-therapy-uptake-126745https://curecurrent.com/trials/casi-plus-mhealth-for-ukraine-s-aps-program-aim-2-126746https://curecurrent.com/trials/prepping-for-the-talk-helping-trusted-adults-and-youth-talk-about-sexual-health-126747https://curecurrent.com/trials/sexual-health-of-sub-saharan-african-migrant-women-recently-diagnosed-with-hiv-in-le-de-france-missed-opportunities-for-126748https://curecurrent.com/trials/pneumococcal-conjugate-vaccination-in-hiv-in-comparison-to-polysaccharide-vaccine-boosting-126749https://curecurrent.com/trials/text-education-about-cardiovascular-health-and-hiv-teach-hiv-126750https://curecurrent.com/trials/linking-high-risk-jail-detainees-to-hiv-pre-exposure-prophylaxis-prep-link-126751https://curecurrent.com/trials/incidence-of-hpv-infection-and-hpv-associated-disease-in-screening-indian-men-who-have-sex-with-hiv-positive-men-126752https://curecurrent.com/trials/incidence-of-hiv-infection-in-screening-indian-men-who-have-sex-with-men-126753https://curecurrent.com/trials/utilizing-private-pharmacies-to-initiate-high-risk-young-individuals-on-prep-in-south-africa-126754https://curecurrent.com/trials/an-hiv-status-neutral-microeconomic-intervention-126755https://curecurrent.com/trials/evaluating-the-safety-and-pharmacokinetics-of-vrc07-523ls-in-the-sera-and-mucosae-of-healthy-hiv-uninfected-adult-partic-126756https://curecurrent.com/trials/pregnant-women-s-coop-126757https://curecurrent.com/trials/pneumocystis-in-patients-over-75-year-126758https://curecurrent.com/trials/testing-integrative-smoking-cessation-for-hiv-patients-126759https://curecurrent.com/trials/rapid-antiretroviral-treatment-initiation-with-bic-ftc-taf-in-hiv-infected-people-who-inject-drugs-pwid-126760https://curecurrent.com/trials/antiretroviral-therapy-for-acute-and-chronic-hiv-infection-126761https://curecurrent.com/trials/buddhism-beliefs-and-hiv-stigma-in-thailand-126762https://curecurrent.com/trials/behavioral-intervention-for-prep-service-utilization-among-chinese-msm-a-hapa-and-cei-integrated-model-126763https://curecurrent.com/trials/web-based-cognitive-behavioral-stress-management-for-latino-sexual-minority-men-living-with-hiv-and-cancer-126764https://curecurrent.com/trials/supervised-treadmill-intervention-to-reduce-inflammation-and-depression-through-exercise-in-hiv-the-stride-pilot-study-126765https://curecurrent.com/trials/combined-modality-therapy-for-patients-with-with-hiv-and-stage-i-stage-ii-or-stage-iii-anal-cancer-126766https://curecurrent.com/trials/a-mobile-phone-sms-intervention-to-increase-retention-in-hiv-care-among-hiv-positive-msm-in-peru-weltel-peru-126767https://curecurrent.com/trials/an-electronic-health-record-based-approach-to-increase-prep-knowledge-and-uptake-the-emc2-prep-strategy-126768https://curecurrent.com/trials/hiv-related-insomnia-and-inflammation-126769https://curecurrent.com/trials/efficacy-testing-of-a-culturally-relevant-stigma-intervention-with-wlwh-in-tanzania-126770https://curecurrent.com/trials/mitigating-sexual-stigma-within-healthcare-interactions-improve-engagement-of-msm-in-hiv-prevention-126771https://curecurrent.com/trials/pharmacy-based-pre-exposure-prophylaxis-126772https://curecurrent.com/trials/safety-tolerability-and-immunogenicity-study-of-different-vaccine-regimens-of-trivalent-ad26-mos-hiv-or-tetravalent-ad26-126773https://curecurrent.com/trials/a-safety-tolerability-and-immunogenicity-study-of-2-different-regimens-of-tetravalent-ad26-mos4-hiv-prime-followed-by-bo-126774https://curecurrent.com/trials/study-to-evaluate-the-safety-and-immunogenicity-of-an-hiv-1-vaccine-regimen-of-adjuvanted-uvax-1107-followed-by-adjuvant-126775https://curecurrent.com/trials/long-acting-cabotegravir-plus-vrc-hivmab075-00-ab-vrc07-523ls-for-viral-suppression-in-adults-living-with-hiv-1-126776https://curecurrent.com/trials/real-world-use-of-lenacapavir-as-an-add-on-to-an-optimized-background-regimen-in-france-126777https://curecurrent.com/trials/neurofeedback-training-nft-on-sleep-quality-and-cognitive-function-performance-among-hiv-infected-persons-126778https://curecurrent.com/trials/take-steps-motivational-interviewing-to-prevent-stis-126779https://curecurrent.com/trials/tele-coaching-community-based-exercise-cbe-study-126780https://curecurrent.com/trials/safety-tolerability-and-acceptability-of-long-acting-cabotegravir-cab-la-for-the-prevention-of-hiv-among-adolescent-male-126781https://curecurrent.com/trials/entrust-economic-navigation-and-strengthening-to-realize-unrestricted-services-for-transgender-women-126782https://curecurrent.com/trials/study-with-dual-therapy-including-lamivudine-300-mg-qd-plus-raltegravir-1200-mg-qd-in-virologically-suppressed-hiv-1-inf-126783https://curecurrent.com/trials/a-social-media-intervention-to-improve-retention-in-care-for-adolescents-and-young-adults-with-hiv-in-uganda-126784https://curecurrent.com/trials/artesunate-suppositories-for-the-treatment-of-hiv-negative-patients-with-intra-anal-hsil-126785https://curecurrent.com/trials/artesunate-ointment-for-the-treatment-of-anal-hsil-in-hiv-negative-participants-126786https://curecurrent.com/trials/effects-of-gender-affirming-hormone-therapy-among-transgender-women-126787https://curecurrent.com/trials/adapting-the-finding-respect-and-ending-stigma-around-hiv-fresh-intervention-for-the-dominican-republic-126788https://curecurrent.com/trials/evaluation-of-long-term-immunogenicity-of-a-boost-dose-of-mva-bn-vaccine-126789https://curecurrent.com/trials/selection-of-resistant-mutations-to-dolutegravir-in-plwh-treated-in-mozambique-126790https://curecurrent.com/trials/our-family-our-future-a-resilience-oriented-family-intervention-to-prevent-adolescent-hiv-sti-infection-and-depression-i-126791https://curecurrent.com/trials/casi-plus-mhealth-for-ukraine-s-aps-program-aim-1-126792https://curecurrent.com/trials/a-mobile-gaming-app-to-improve-adherence-to-prep-126793https://curecurrent.com/trials/delivering-a-multi-disease-screening-tool-to-migrant-populations-126794https://curecurrent.com/trials/fostemsavir-compassionate-use-named-patient-program-for-the-treatment-of-human-immunodeficiency-virus-1-hiv-1-126795https://curecurrent.com/trials/project-matlink-development-and-evaluation-of-a-screening-brief-intervention-referral-to-treatment-sbirt-program-for-opi-126796https://curecurrent.com/trials/scaling-up-an-evidence-based-intervention-for-antiretroviral-therapy-for-pwid-in-vietnam-an-implementation-trial-126797https://curecurrent.com/trials/oraquick-hiv-self-test-study-in-canada-126798https://curecurrent.com/trials/options-for-delivering-isoniazid-rifapentine-3hp-for-tb-prevention-3hp-options-implementation-trial-126799https://curecurrent.com/trials/making-prep-smart-an-hiv-testing-and-prep-electronic-support-tool-smartprep-app-for-women-on-prep-126800https://curecurrent.com/trials/cohort-study-of-hiv-positive-people-treated-with-long-acting-antiretroviral-therapy-126801https://curecurrent.com/trials/italian-registry-of-hiv-1-infected-patients-with-drug-resistant-virus-to-reverse-transcriptase-inhibitors-integrase-and-126802https://curecurrent.com/trials/hptn-073-black-men-who-have-sex-with-men-msm-pre-exposure-prophylaxis-prep-126803https://curecurrent.com/trials/screen-smart-using-digital-health-to-improve-hiv-screening-and-prevention-126804https://curecurrent.com/trials/harnessing-male-peer-networks-to-enhance-engagement-with-hiv-prevention-126805https://curecurrent.com/trials/pre-exposure-prophylaxis-prep-for-health-126806https://curecurrent.com/trials/the-role-of-probiotics-in-hiv-patients-with-immunological-non-responder-126807https://curecurrent.com/trials/long-term-outcomes-of-therapy-in-women-initiated-on-lifelong-art-because-of-pregnancy-in-dr-congo-126808https://curecurrent.com/trials/promoting-safer-sexual-dual-protection-behaviors-for-female-university-students-to-reduce-risks-of-both-sti-hiv-and-unin-126809https://curecurrent.com/trials/a-study-to-assess-safety-and-immunogenicity-of-conserved-mosaic-hiv-1-vaccines-126810https://curecurrent.com/trials/self-test-strategies-and-linkage-incentives-to-improve-art-and-prep-uptake-in-men-126811https://curecurrent.com/trials/immunogenicity-and-safety-of-hecolin-in-hiv-positive-negative-adults-and-in-children-126812https://curecurrent.com/trials/hiv-1-specific-t-cells-hst-neets-for-hiv-infected-individuals-126813https://curecurrent.com/trials/the-community-prep-study-to-assess-the-acceptance-of-prep-delivered-through-cbct-platforms-126814https://curecurrent.com/trials/safety-and-tolerability-of-aav8-delivery-of-a-broadly-neutralizing-antibody-in-adults-living-with-hiv-a-phase-1-dose-esc-126815https://curecurrent.com/trials/a-gender-transformative-implementation-strategy-with-providers-to-improve-hiv-outcomes-in-uganda-126816https://curecurrent.com/trials/addressing-violence-and-hiv-care-among-transgender-women-126817https://curecurrent.com/trials/cancer-prevalence-and-outcomes-in-individuals-with-hiv-and-aids-multicenter-buhasder-study-126818https://curecurrent.com/trials/the-effectiveness-of-high-resolution-microendoscopy-for-people-living-with-hiv-126819https://curecurrent.com/trials/reducing-post-hospital-mortality-in-hiv-infected-adults-in-tanzania-126820https://curecurrent.com/trials/vh3739937-phase-1-multiple-ascending-dose-mad-study-in-healthy-volunteers-including-relative-bioavailability-rba-optiona-126821https://curecurrent.com/trials/neurodevelopmental-assessment-of-children-in-uganda-and-malawi-using-a-software-package-126822https://curecurrent.com/trials/telehealth-to-reduce-suicidality-and-improve-hiv-care-engagement-in-tanzania-126823https://curecurrent.com/trials/better-than-study-targeting-heavy-alcohol-use-with-naltrexone-among-men-who-have-sex-with-men-msm-126824https://curecurrent.com/trials/empathy-in-frames-animated-cartoons-to-reduce-hiv-stigma-among-south-african-young-adults-126825https://curecurrent.com/trials/analytical-treatment-interruption-ati-to-assess-the-immune-system-s-ability-to-control-hiv-in-participants-who-became-hi-126826https://curecurrent.com/trials/early-administration-of-romidepsin-and-3bnc117-in-treatment-na-ve-hiv-patients-starting-art-126827https://curecurrent.com/trials/immunogenicity-of-gardasil-9-hpv-vaccine-in-people-living-with-hiv-126828https://curecurrent.com/trials/one-stop-prep-care-pathway-to-simplify-prep-delivery-in-kenya-the-one-stop-prep-care-project-126829https://curecurrent.com/trials/impact-of-representative-payee-services-on-art-adherence-among-marginalized-people-living-with-hiv-aids-126830https://curecurrent.com/trials/extended-duration-artemether-lumefantrine-treatment-for-malaria-in-children-126831https://curecurrent.com/trials/efficacy-and-safety-of-dtg-3tc-in-treatment-na-ve-hiv-1-infected-patients-126832https://curecurrent.com/trials/a-patient-portal-and-proms-to-improve-health-problem-detection-and-retention-in-hiv-care-the-drhive-study-126833https://curecurrent.com/trials/a-study-of-zidovudine-lamivudine-and-either-nevirapine-or-nelfinavir-for-reduction-of-mother-to-child-hiv-transmission-d-126834https://curecurrent.com/trials/incentives-and-reminders-to-improve-long-term-medication-adherence-126835https://curecurrent.com/trials/single-high-dose-of-liposomal-amphotericin-b-in-combination-with-b-f-taf-for-hiv-aids-associated-talaromycosis-126836https://curecurrent.com/trials/reducing-hiv-persistence-in-lymph-nodes-by-interleukin-15-il-15-receptor-super-agonist-n-803-in-acute-hiv-infection-126837https://curecurrent.com/trials/the-mistral-study-gut-microbiome-correlates-of-serious-aids-and-non-aids-events-126838https://curecurrent.com/trials/etest-real-time-remote-monitoring-system-for-home-based-hiv-testing-among-high-risk-men-who-have-sex-with-men-126839https://curecurrent.com/trials/phase-ii-trial-of-brecadd-in-hiv-positive-patients-with-advanced-stage-classical-hodgkin-lymphoma-126840https://curecurrent.com/trials/kyaterekera-project-a-combination-intervention-addressing-sexual-risk-taking-behaviors-among-vulnerable-women-in-uganda-126841https://curecurrent.com/trials/kharituwe-tb-contact-tracing-study-126842https://curecurrent.com/trials/hiv-1-non-group-m-in-cameroon-study-of-genotypic-and-phylogenetic-diversity-obsocam-126843https://curecurrent.com/trials/long-term-follow-up-of-hpv-vaccine-in-hiv-ctn-236-126844https://curecurrent.com/trials/hepatitis-c-pharmacy-based-strategy-for-injectors-126845https://curecurrent.com/trials/evaluation-of-pharmacokinetic-drug-drug-interactions-between-hormonal-contraceptives-and-doravirine-containing-art-among-126846https://curecurrent.com/trials/impact-on-linkage-to-hiv-care-with-point-of-care-cd4-testing-and-home-based-hiv-testing-in-kenya-126847https://curecurrent.com/trials/supporting-treatment-outcomes-among-pwid-126848https://curecurrent.com/trials/a-mobile-gaming-app-to-improve-art-adherence-for-youth-126849https://curecurrent.com/trials/preloading-with-nicotine-replacement-therapy-in-hiv-positive-smokers-to-improve-self-efficacy-and-quit-attempts-126850https://curecurrent.com/trials/effectiveness-and-safety-of-darunavir-cobicistat-plus-lamivudine-versus-darunavir-cobicistat-plus-tenofovir-emtricitabin-126851https://curecurrent.com/trials/same-day-versus-rapid-art-initiation-in-hiv-positive-individuals-presenting-with-symptoms-of-tuberculosis-126852https://curecurrent.com/trials/tb-capt-exultant-hiv-126853https://curecurrent.com/trials/prep-for-prevention-of-hiv-transmission-among-people-who-inject-drugs-in-nairobi-kenya-126854https://curecurrent.com/trials/impact-of-nmn-supplementation-on-cd4-t-cell-recovery-in-hiv-patients-with-immunological-failure-126855https://curecurrent.com/trials/prevention-access-to-rights-catch-up-vaccination-treatment-of-conditions-during-pregnancy-and-for-children-126856https://curecurrent.com/trials/rezafungin-for-treatment-of-pneumocystis-pneumonia-in-hiv-adults-126857https://curecurrent.com/trials/prospective-multicenter-study-of-the-relationship-between-virological-effectiveness-and-compliance-in-hiv-1-infected-pat-126858https://curecurrent.com/trials/technology-based-training-tool-for-phat-life-126859https://curecurrent.com/trials/prospective-observational-study-on-the-incidence-of-opportunistic-fungal-infections-126860https://curecurrent.com/trials/stigma-among-women-with-hiv-in-vietnam-126861https://curecurrent.com/trials/positive-deviance-to-improve-retention-in-hiv-care-hiv-care-in-south-africa-126862https://curecurrent.com/trials/integrated-treatment-and-prevention-for-people-who-inject-drugs-126863https://curecurrent.com/trials/an-affirmative-coping-skills-intervention-to-improve-mental-and-sexual-health-of-sexual-and-gender-minority-youth-126864https://curecurrent.com/trials/evaluating-methods-to-increase-hiv-testing-access-to-hiv-care-and-hiv-prevention-strategies-126865https://curecurrent.com/trials/complementary-therapies-in-the-aging-process-of-people-living-with-hiv-126866https://curecurrent.com/trials/study-using-cabenuva-for-the-treatment-of-human-immunodeficiency-virus-hiv-1-administered-in-infusion-centers-ic-or-alte-126867https://curecurrent.com/trials/first-time-in-human-ftih-study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-pk-of-vh4011499-in-healthy-parti-126868https://curecurrent.com/trials/antiretroviral-pregnancy-registry-apr-multi-sponsor-registry-to-detect-any-major-teratogenic-effect-involving-any-of-the-126869https://curecurrent.com/trials/trac-er-intervention-to-reduce-risky-alcohol-use-and-hiv-risk-126870https://curecurrent.com/trials/a-study-of-darunavir-cobicistat-emtricitabine-tenofovir-alafenamide-d-c-f-taf-evaluated-as-a-fixed-dose-combination-regi-126871https://curecurrent.com/trials/a-study-of-mgd020-alone-or-combined-with-mgd014-in-persons-with-hiv-1-on-antiretroviral-therapy-126872https://curecurrent.com/trials/hiv-self-testing-of-male-partners-of-women-in-pmtct-126873https://curecurrent.com/trials/the-adapt-study-use-of-emtricitabine-and-tenofovir-disoproxil-fumarate-for-pre-exposure-prophylaxis-prep-126874https://curecurrent.com/trials/feasibility-of-hiv-prevention-cohort-studies-among-men-who-have-sex-with-men-in-sub-saharan-africa-126875https://curecurrent.com/trials/evaluating-drug-interactions-between-doravirine-with-estradiol-and-spironolactone-in-healthy-transgender-women-126876https://curecurrent.com/trials/whatsapp-intervention-to-assess-the-effect-of-messages-in-adherence-to-antiretrovirals-in-young-people-with-hiv-in-peru-126877https://curecurrent.com/trials/effectiveness-of-smartphone-application-for-adherence-support-vuka-126878https://curecurrent.com/trials/a-study-to-assess-the-safety-and-immune-response-to-env-c-dna-and-protein-vaccines-in-kenya-126879https://curecurrent.com/trials/a-clinical-trial-in-adult-participants-without-hiv-and-in-overall-good-health-to-evaluate-the-safety-and-immunogenicity-126880https://curecurrent.com/trials/mk-8527-single-dose-trial-in-hiv-1-infected-participants-mk-8527-004-126881https://curecurrent.com/trials/a-trial-of-cobicistat-and-gemcitabine-and-nab-paclitaxel-in-patients-with-advanced-stage-or-metastatic-pancreatic-ductal-126882https://curecurrent.com/trials/ayaangwaamiziwin-initiative-carefulness-and-preparedness-126883https://curecurrent.com/trials/a-comparison-of-different-community-models-of-art-delivery-amongst-stable-hiv-patients-in-two-urban-settings-in-zambia-126884https://curecurrent.com/trials/clinical-opportunities-and-management-to-exploit-biktarvy-as-asynchronous-connection-key-comeback-126885https://curecurrent.com/trials/effects-of-cash-transfer-for-the-prevention-of-hiv-in-young-south-african-women-126886https://curecurrent.com/trials/enhancing-recruitment-linkage-to-care-and-treatment-for-hiv-infected-msm-in-the-united-states-126887https://curecurrent.com/trials/prevention-and-treatment-continuum-for-youth-at-hiv-risk-acutely-infected-and-with-established-hiv-infection-126888https://curecurrent.com/trials/dose-proportionality-and-intra-individual-variability-of-intracellular-tfv-dp-and-ftc-tp-in-healthy-volunteers-126889https://curecurrent.com/trials/a-multicomponent-intervention-to-address-gender-based-violence-in-hiv-126890https://curecurrent.com/trials/hdv-screening-study-126891https://curecurrent.com/trials/hiv-1-coronavirus-coinfection-in-europe-morbidity-risk-factors-of-covid-19-in-people-living-with-hiv-126892https://curecurrent.com/trials/assessing-perceptions-and-preferences-around-long-acting-injectables-appli-126893https://curecurrent.com/trials/the-shauriana-intervention-for-gbmsm-in-kenya-126894https://curecurrent.com/trials/hiv-clinic-based-intervention-to-improve-art-adherence-and-prevent-hiv-transmission-126895https://curecurrent.com/trials/hiv-sti-risk-reduction-for-incarcerated-women-with-interpersonal-violence-126896https://curecurrent.com/trials/improving-cervical-cancer-screening-in-women-living-with-hiv-attending-chronic-disease-clinics-in-semi-rural-tanzania-126897https://curecurrent.com/trials/integrated-prep-interventions-for-people-who-inject-drugs-in-rural-kentucky-126898https://curecurrent.com/trials/als-research-collaborative-126899https://curecurrent.com/trials/evaluation-of-the-efficacy-and-mechanisms-of-a-novel-intervention-for-chronic-pain-tailored-to-people-living-with-hiv-126900https://curecurrent.com/trials/access-hiv-ag-ab-combo-assay-european-union-eu-clinical-trial-protocol-126901https://curecurrent.com/trials/reaching-the-last-20-the-pamoja-kwa-afya-study-126902https://curecurrent.com/trials/mhealth-hiv-prevention-for-transgender-women-126903https://curecurrent.com/trials/eswatini-ring-study-increasing-prep-options-for-women-126904https://curecurrent.com/trials/effects-of-art-simplification-on-inflammatory-markers-in-coris-air-126905https://curecurrent.com/trials/biobehavioral-interventions-for-hiv-negative-stimulant-using-men-who-have-sex-with-men-126906https://curecurrent.com/trials/treatment-of-hiv-hcv-coinfection-with-peg-ifn-and-ribavirin-in-patients-receiving-art-monotherapy-with-lopinavir-r-126907https://curecurrent.com/trials/impact-of-dolutegravir-lamivudine-simplification-on-hiv-1-reservoirs-126908https://curecurrent.com/trials/a-prospective-cohort-of-children-with-hiv-infection-126909https://curecurrent.com/trials/accelerated-genital-tract-aging-in-hiv-estradiol-clinical-trial-126910https://curecurrent.com/trials/a-multicomponent-intervention-to-increase-hiv-risk-perceptions-and-prep-initiation-among-black-men-who-have-sex-with-men-126911https://curecurrent.com/trials/mosaic-hiv-1-envelope-trimer-immunogens-administered-to-people-living-with-hiv-plwh-in-africa-126912https://curecurrent.com/trials/randomized-trial-of-liposomal-amphotericin-b-for-histoplasmosis-in-aids-patients-126913https://curecurrent.com/trials/automated-medication-platform-with-video-observation-and-facial-recognition-to-improve-adherence-to-antiretroviral-thera-126914https://curecurrent.com/trials/dihydroartemisinin-piperaquine-in-the-context-of-antiretroviral-therapy-126915https://curecurrent.com/trials/optimizing-smoking-cessation-for-people-with-hiv-aids-who-smoke-126916https://curecurrent.com/trials/the-catalyst-study-126917https://curecurrent.com/trials/intervention-to-enhance-prep-persistence-126918https://curecurrent.com/trials/quantification-of-antisense-hiv-rna-in-patients-126919https://curecurrent.com/trials/mhealth-technologies-to-enhance-prep-adherence-among-thai-msm-126920https://curecurrent.com/trials/oligonucleotide-ligation-assay-ola-resistance-study-126921https://curecurrent.com/trials/safety-tolerability-and-efficacy-of-a-dose-reduction-strategy-based-on-bictegravir-emtricitabine-tenofovir-alafenamide-i-126922https://curecurrent.com/trials/mypeeps-mobile-for-young-transgender-men-126923https://curecurrent.com/trials/alcohol-research-consortium-in-hiv-intervention-research-arm-126924https://curecurrent.com/trials/predictors-of-health-service-utilizations-among-key-population-in-washington-dc-126925https://curecurrent.com/trials/neuropathy-walks-cross-sectional-126926https://curecurrent.com/trials/community-health-worker-and-mhealth-to-improve-viral-suppression-champs-pilot-126927https://curecurrent.com/trials/potential-of-prebiotic-galacto-oligosaccharides-in-improving-efficacy-and-safety-of-oral-iron-supplementation-in-hiv-inf-126928https://curecurrent.com/trials/development-of-a-health-related-symptom-index-for-participants-with-and-either-treated-or-monitored-for-anal-high-grade-126929https://curecurrent.com/trials/community-health-worker-training-to-reduce-depression-and-substance-use-stigma-in-tb-hiv-care-in-south-africa-126930https://curecurrent.com/trials/development-of-a-predictive-model-for-sexually-transmitted-infections-in-individuals-using-pre-exposure-prophylaxis-for-126931https://curecurrent.com/trials/information-visualizations-to-enhance-hiv-related-communication-126932https://curecurrent.com/trials/an-evaluation-of-tc-99m-tilmanocept-by-intravenous-iv-and-subcutaneous-sc-injection-in-kaposi-sarcoma-ks-126933https://curecurrent.com/trials/mlab-app-plus-a-randomized-controlled-trial-of-a-mobile-health-mhealth-intervention-126934https://curecurrent.com/trials/prevention-of-missed-opportunities-for-hiv-diagnosis-by-promoting-hiv-testing-of-patients-with-pneumococcal-pneumonia-at-126935https://curecurrent.com/trials/a-study-to-evaluate-the-anti-inflammatory-effects-of-letermovir-prevymis-in-adults-with-human-immunodeficiency-virus-hiv-126936https://curecurrent.com/trials/cpt-l-to-improve-outcomes-for-individuals-with-hiv-and-ptsd-126937https://curecurrent.com/trials/tools-to-identify-people-at-risk-or-already-infected-with-hiv-and-hcv-126938https://curecurrent.com/trials/factors-associated-with-advanced-hiv-and-poor-nutrition-among-people-living-with-hiv-126939https://curecurrent.com/trials/hiv-resistance-molecular-epidemiology-and-new-treatment-strategies-in-the-eastern-european-region-and-in-russia-126940https://curecurrent.com/trials/suubi4cancer-improving-access-to-pediatric-cancer-services-and-treatment-adherence-among-children-living-with-hiv-aids-126941https://curecurrent.com/trials/weprep-developing-a-prep-shared-decision-making-tool-for-transgender-women-126942https://curecurrent.com/trials/testing-implementation-strategies-to-improve-delivery-of-prep-for-pregnant-and-postpartum-women-in-kenya-126943https://curecurrent.com/trials/prevalence-of-drug-resistant-hiv-1-strains-in-patients-experiencing-virologic-failure-multivir2025-126944https://curecurrent.com/trials/a-study-to-evaluate-aav9-neutralizing-antibody-seroconversion-in-household-contacts-126945https://curecurrent.com/trials/impact-of-malnutrition-on-pharmacokinetic-of-rifampicin-isoniazid-pyrazinamide-and-ethambutol-in-tb-hiv-co-infected-chil-126946https://curecurrent.com/trials/cabenuva-injection-tracking-in-chorus-126947https://curecurrent.com/trials/epividian-ahf-positive-pathways-hiv-retention-in-care-126948https://curecurrent.com/trials/hiv-pre-exposure-prophylaxis-among-an-unrecognized-sexual-minority-population-126949https://curecurrent.com/trials/development-of-a-new-family-of-hiv-latency-regulators-lras-targeting-the-tat-viral-protein-126950https://curecurrent.com/trials/dolutegravir-in-pregnant-hiv-mothers-and-their-neonates-126951https://curecurrent.com/trials/substituting-smss-for-provider-delivered-care-to-improve-alcohol-use-outcomes-126952https://curecurrent.com/trials/primary-resistance-in-hiv-patients-in-colombia-126953https://curecurrent.com/trials/evaluating-the-pharmacokinetics-feasibility-acceptability-and-safety-of-oral-pre-exposure-prophylaxis-for-hiv-prevention-126954https://curecurrent.com/trials/urban-and-insular-study-on-treatment-experiences-and-stigma-in-people-living-with-hiv-126955https://curecurrent.com/trials/community-intervention-for-hiv-testing-care-linkage-among-young-msm-in-bulgaria-126956https://curecurrent.com/trials/a-study-to-investigate-the-effect-of-food-on-the-bioavailability-of-a-capsid-inhibitor-cai-in-male-and-female-healthy-pa-126957https://curecurrent.com/trials/community-health-worker-and-mhealth-to-improve-viral-suppression-126958https://curecurrent.com/trials/same-day-restart-of-b-f-taf-in-hiv-patients-after-nnrti-discontinuation-126959https://curecurrent.com/trials/vaccination-against-human-papillomavirus-hpv-with-the-9-valent-vaccine-in-hiv-positive-women-the-papillon-study-126960https://curecurrent.com/trials/real-life-outcomes-of-taf-ftc-bic-in-hiv-patients-in-colombia-126961https://curecurrent.com/trials/a-pharmacist-run-prep-program-for-women-126962https://curecurrent.com/trials/aspects-of-vulnerability-of-people-living-with-hiv-in-the-alpine-arc-region-126963https://curecurrent.com/trials/syndemics-and-loss-from-the-hiv-care-continuum-in-india-intervention-126964https://curecurrent.com/trials/functional-decline-and-qol-in-people-aging-with-hiv-in-asia-126965https://curecurrent.com/trials/oral-doxycycline-for-the-prevention-of-syphilis-in-men-who-have-sex-with-men-dadhs-126966https://curecurrent.com/trials/prep-and-alcohol-enhancing-hiv-pre-exposure-prophylaxis-prep-126967https://curecurrent.com/trials/efficacy-safety-and-immunogenicity-evaluation-of-mtbvac-in-newborns-in-sub-saharan-africa-126968https://curecurrent.com/trials/a-clinical-trial-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-pgdm1400ls-alone-and-in-combination-with-vr-126969https://curecurrent.com/trials/siyakhana-peer-evaluating-a-peer-recovery-coach-model-to-reduce-substance-use-stigma-in-south-african-hiv-care-126970https://curecurrent.com/trials/making-an-early-diagnosis-of-talaromycosis-using-a-novel-antigen-test-126971https://curecurrent.com/trials/package-of-resources-for-assisted-contact-tracing-implementation-costs-and-effectiveness-126972https://curecurrent.com/trials/pharmacokinetics-of-antiretroviral-drugs-in-lactating-women-and-breastmilk-fed-infants-under-6-months-of-age-in-botswana-126973https://curecurrent.com/trials/smoking-cessation-interventions-for-people-living-with-hiv-in-nairobi-kenya-126974https://curecurrent.com/trials/study-evaluating-the-safety-in-terms-of-hbv-virological-control-at-96-weeks-of-2-antiviral-treatment-relief-strategies-i-126975https://curecurrent.com/trials/use-of-long-acting-injectable-cabotegravir-rilpivirine-for-the-treatment-of-hiv-in-belgium-126976https://curecurrent.com/trials/prepared-to-choose-ptc-is-an-implementation-study-of-the-delivery-of-cabotegravir-long-acting-an-injectable-pre-exposure-126977https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-d-c-f-taf-once-daily-fixed-dose-combination-fdc-regimen-in-newly-diagnose-126978https://curecurrent.com/trials/a-study-of-2-different-regimens-of-tetravalent-ad26-mos4-hiv-prime-followed-by-boost-with-modified-vaccinia-ankara-mva-m-126979https://curecurrent.com/trials/safety-and-efficacy-study-of-vaccine-schedule-with-ad26-mos-hiv-and-mva-mosaic-in-human-immunodeficiency-virus-hiv-infec-126980https://curecurrent.com/trials/a-study-of-switching-to-rpv-plus-other-arvs-in-hiv-1-infected-children-aged-2-to-12-years-who-are-virologically-suppress-126981https://curecurrent.com/trials/safety-tolerability-and-immunogenicity-study-of-homologous-ad26-mosaic-vector-vaccine-regimens-or-heterologous-ad26-mosa-126982https://curecurrent.com/trials/safety-tolerability-and-immunogenicity-study-of-different-vaccine-schedules-with-ad26-mos-hiv-and-clade-c-glycoprotein-g-126983https://curecurrent.com/trials/a-bioequivalence-study-of-darunavir-emtricitabine-and-tenofovir-alafenamide-in-the-presence-of-cobicistat-in-healthy-par-126984https://curecurrent.com/trials/epic-p-intervention-126985https://curecurrent.com/trials/intensive-models-of-hcv-care-for-injection-drug-users-126986https://curecurrent.com/trials/acute-coronary-syndrome-kcmc-126987https://curecurrent.com/trials/an-open-label-non-randomized-single-arm-study-to-investigate-the-mechanism-s-by-which-nevirapine-increases-plasma-hdl-in-126988https://curecurrent.com/trials/safety-and-immunogenicity-of-hiv-dna-c-cn54env-and-recombinant-hiv-cn54gp140-vaccines-in-healthy-volunteers-126989https://curecurrent.com/trials/negative-serology-by-immunoenzymatic-test-eia-in-hiv-infected-children-treated-early-with-antiretroviral-in-the-anrs-ped-126990https://curecurrent.com/trials/aging-with-hiv-and-neurocognitive-decline-a-follow-up-study-126991https://curecurrent.com/trials/biomedical-hiv-aids-prevention-program-yunnan-126992https://curecurrent.com/trials/identification-of-barriers-and-facilitators-of-implementation-of-the-out-of-hospital-administration-of-the-long-acting-c-126993https://curecurrent.com/trials/phase-1-open-label-single-dose-study-to-examine-safety-tolerability-pharmacokinetics-and-virologic-impact-of-vrc01ls-or-126994https://curecurrent.com/trials/outcome-at-5-years-of-early-treated-hiv-infected-infants-in-the-pediacam-project-126995https://curecurrent.com/trials/the-cedar-project-impact-of-mhealth-for-hiv-prevention-among-young-indigenous-people-who-use-illicit-drugs-126996https://curecurrent.com/trials/zepatier-in-patients-with-substance-use-126997https://curecurrent.com/trials/hiv-and-changes-in-the-gut-microbiome-after-changes-in-antiretroviral-therapy-art-126998https://curecurrent.com/trials/host-genome-methylation-a-screening-tool-in-anal-cancer-detection-126999https://curecurrent.com/trials/peer-delivered-hiv-syphilis-self-testing-with-assisted-partner-notification-services-127000https://curecurrent.com/trials/covid-19-serology-in-people-living-with-hiv-in-hong-kong-127001https://curecurrent.com/trials/chemsex-engagement-and-hiv-biomedical-prevention-in-msm-127002https://curecurrent.com/trials/combine-2-real-world-evidence-for-effectiveness-of-two-drug-regimen-antiretroviral-therapy-with-integrase-inhibitors-plu-127003https://curecurrent.com/trials/pharmacokinetics-pk-of-tipranavir-ritonavir-ribavirin-pegylated-interferon-peg-inf-in-hepatitis-c-hcv-subjects-with-mild-127004https://curecurrent.com/trials/a-combination-efficacy-study-in-africa-of-two-dna-mva-env-protein-or-dna-env-protein-hiv-1-vaccine-regimens-with-prep-127005https://curecurrent.com/trials/a-drug-drug-interaction-study-of-mk-8527-with-a-combined-oral-contraceptive-lng-ee-127006https://curecurrent.com/trials/a-comprehensive-hiv-prevention-package-for-south-african-adolescent-girls-and-young-women-127007